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1. Introductory chapter 
 Chapter One is a systematic review that aims to investigate the relationship between 
glycaemic control and quality of life (QoL) in adults with Type 1 Insulin-Dependent Diabetes 
Mellitus (IDDM). The National Institute for Health and Care Excellence (NICE, 2015) 
proposes that adults with IDDM should aim to achieve a near-normal glycaemic range, as 
indicated by the measurement of glycated haemoglobin (HbA1c), to reduce the risk of severe 
life-changing complications. Anecdotally, in clinical practice, it is assumed that those who 
achieve good glycaemic control and meet the required HbA1c target also have good QoL; 
however, striving for a near normal HbA1c, and the associated treatment burden, may have a 
negative impact upon QoL. The negative impact of treatment burden on QoL may be a 
necessary compromise, as achieving a near normal HbA1c is likely to safeguard the person 
from IDDM- related complications in the long-term, which will inevitably impact upon QoL 
later (Rubin & Peyrot, 1999). Therefore, it is not yet established how achieving a near-normal 
HbA1c impacts upon QoL. These issues were brought to life clinically, as the lead researcher 
spent time in the Paediatric Diabetes Department, and this fuelled their interest in 
investigating the relationship between HbA1c and QoL in adults with IDDM. 
 Seven studies are included in the review. Few studies set out to investigate the 
relationship between HbA1c and QoL. The overall quality of the research is poor. Three of 
the seven studies indicated that there was no relationship between HbA1c and QoL, one study 
identified a negative correlation, one study offered mixed results, and two studies proposed 
that a curve-linear relationship best described their data. Therefore, the review is unable to 
provide a conclusive statement regarding the nature of the relationship between HbA1c and 
QoL. The review does not support the commonly held anecdotal assumption that good 
glycaemic control, as indicated by HbA1c, equates to good QoL. Furthermore, the review 
highlights the limitations of quantitative research design and methodology when investigating 
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a subjective and dynamic phenomenon such as QoL. The limitations found in the quantitative 
studies included in the systematic review informed the design of the empirical investigation 
that employs qualitative methods. 
Chapter Two is an empirical paper that describes a qualitative study that explored 
how adolescents aged 13 to 19 with IDDM experience themselves as able to ‘live well’ 
despite their chronic condition. IDDM is one of the most common childhood conditions in 
the UK, and it requires careful management to reduce the risk of life limiting and life 
changing complications (Spencer, Cooper & Milton, 2010). As with adults, UK healthcare 
policy proposes that young people aim to achieve near normal glycaemic control to reduce 
the risk of IDDM complications (NICE, 2015).  
Adolescents with IDDM typically have poor glycaemic control and this poses a 
significant challenge to diabetes healthcare teams (Burke & Dowling, 2007). The extant 
literature explores ‘barriers’ to control and focuses upon the negative impact of IDDM; it is 
‘problem saturated’ (Balfe et al., 2013). The purpose of this paper was to explore 
qualitatively how some young people are able to experience themselves as living well in 
adolescence despite IDDM.  In contrast to the systematic review of quantitative research 
regarding HbA1c and QoL in adults, this paper uses a qualitative design that specifically 
explores the experiences of adolescents; a population who generally have poor control. 
Furthermore, it is hoped that this positive psychological approach will address a gap in the 
literature and may help deepen the understanding of the psychological and social processes 
that enable some young people to live well with a chronic condition. The lead researcher has 
a longstanding interest in working with adolescents. 
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The empirical paper will be submitted for publication to the British Journal of Health 
Psychology, as it is in keeping with their scope and readership. The British Journal of Health 
Psychology publishes “original research on all aspects of psychology related to health, 
health-related behaviour and illness across the lifespan”.  
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2. Chapter One 
 
A systematic review of the relationship 
between glycaemic control and quality of life 
in adults with Type 1 Insulin-Dependent 
Diabetes Mellitus 
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Abstract 
 
Purpose: Adults with Type 1 Insulin-Dependent Diabetes Mellitus (IDDM) aim to achieve a 
near-normal glycaemic range, as indicated by the measurement of glycated haemoglobin 
(HbA1c), to reduce the risk of severe life-changing complications. It is not yet established 
how achieving a near-normal HbA1c impacts upon quality of life (QoL). The purpose of this 
review was to systematically search for, review and synthesise published research that has 
explored the relationship between glycaemic control (HbA1c) and QoL.  
Method: Research papers were identified via searching four electronic databases and 
reference lists. Studies were included if they were quantitative and available in English; 
included adult participants over the age of 18 diagnosed with IDDM; used a standardised 
self-report measure of QoL or well-being; reported HbA1c and the correlation or regression.  
Seven papers were eligible for inclusion in the review.  
Results: Three of the seven studies indicated that there was no relationship between HbA1c 
and QoL, although correlations with specific subscales were identified. One study identified a 
negative correlation between HbA1c and QoL. A further study offered mixed results: no 
correlation was found between HbA1c and well-being, anxiety and depression; however, a 
positive correlation was identified between HbA1c and diabetes related distress. Two studies 
proposed that a curve-linear relationship best described their data and suggested that those 
with an acceptable HbA1c reported the greatest QoL.  
Conclusions: The review was unable to provide a conclusive statement regarding the nature 
of the relationship between HbA1c and QoL. Further research needs to be undertaken to 
capture the multifaceted and dynamic nature of QoL and how this relates to glycaemic 
control for people with IDDM. 
Key words: Type 1 Diabetes, Adults, Glycaemic Control, HbA1c, Quality of Life, 
Systematic Review 
Word count 5,996 
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Introduction 
Type 1 Insulin-Dependent Diabetes Mellitus 
Diabetes UK (2016) estimate that there are 3.5 million people diagnosed with diabetes in 
the UK. They propose that this estimate is conservative and that the actual number of people 
with diabetes is almost 4 million, as a large number are undiagnosed. The figure of 3.5 
million is an increase of 1.4 million people since 1996, and is expected to exceed 5 million by 
the year 2025. Diabetes is a growing public health concern that costs the NHS an estimated 
10 billion pounds annually (Diabetes UK, 2016). 
Most people are diagnosed with Type 2 diabetes, which often occurs in older people with 
other medical problems, such as obesity (Hanas, 2015). In Type 2 diabetes, the body is 
unable to produce enough insulin, or does not respond to the insulin that is produced (Hanas, 
2015). Type 1 Insulin-Dependent Diabetes Mellitus (IDDM) is used to describe diabetes 
when the body is unable to produce insulin. In the UK, an estimated 350,000 people are 
diagnosed with IDDM (Diabetes UK, 2016). People are more likely to develop the condition 
in childhood and it is thought that certain people may be genetically predisposed. It is 
understood as an autoimmune disease in which the body destroys the beta cells of the 
pancreas and they subsequently fail to produce any insulin (Hanas, 2015). Blood glucose is 
controlled by synthetic insulin that must be administered via injections or an insulin pump. 
Type 2 diabetes can also develop into IDDM, when the diabetes progresses and it is no longer 
possible to achieve satisfactory glycaemic control through oral medication alone (Hanas, 
2015). 
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Self-care to reduce the risk of complications 
People who are diagnosed with IDDM must cope with a daily regimen of blood tests, 
understand nutritional information and diet, monitor activity and energy expenditure, 
calculate the required insulin dose, and finally, inject themselves with insulin (Hanas, 2015).  
IDDM requires careful management to reduce the risk of severe, life-changing consequences, 
for example heart and blood vessel disease, neuropathy (nerve damage), nephropathy (kidney 
damage), eye damage, foot damage, skin and mouth conditions and complications during 
pregnancy (Diabetes UK, 2016).  
The Diabetes Control and Complication Trial (DCCT, 1993) indicated that the risk of 
complications can be reduced by aiming to achieve a near normal glycaemic range, as 
indicated by the measurement of glycated haemoglobin (HbA1c). HbA1c is a measure of the 
percentage of the haemoglobin in the red blood cells that has glucose bound to it. It is an 
average measure of how well a person’s diabetes has been controlled over the previous three 
months (Hanas, 2015). The findings in the DCCT (1993) have been replicated and this 
strengthened the robust evidence base that advocates that people should aim to achieve a near 
normal glycaemic range (EURODIAB IDDM Complications Study Group, 1994).  
Healthcare policy 
Healthcare for adults with IDDM focuses upon achieving near normal glycaemic control 
to reduce the risk of complications (The National Institute for Health and Care Excellence; 
NICE, 2015). NICE (2015) advises HbA1c levels to be checked every three to six months 
and that the target should be 48mmol/mol (6.5%) or lower, to minimise the risk of long-term 
vascular complications. It is important to note that the guidance also advises that an 
‘individual target’ should be agreed and to monitor self-reported episodes of hypoglycaemia 
(low blood glucose); however, the emphasis is upon achieving a near normal HbA1c (NICE, 
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2015). Most adults with IDDM fail to meet their HbA1c target (NICE, 2015). It is unclear 
what impact this may have on QoL. Anecdotally, in healthcare, there appears to be an 
assumption that achieving the required HbA1c target equates to improved QoL. However, 
striving to achieve the set HbA1c target may be experienced as a burden which diminishes 
QoL, albeit reducing the risk of complications that may impact upon QoL in later life 
(DCCT, 1993; Rubin & Peyrot, 1999).   
Quality of Life (QoL) 
The World Health Organisation (1997:5) defines QoL as:  
“an individual’s perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns. It is a broad ranging concept affected in a complex way by the person's physical 
health, psychological state, level of independence, social relationships, personal beliefs and 
their relationship to salient features of their environment”. (p. 5) 
Speight, Reaney and Barnard (2009) proposed that there is a general consensus that quality of 
life is multidimensional (physical, psychological and social), subjective (each individual has 
their own perceptions about different aspects of their life) and dynamic (changing over time 
or in response to various influences).  
QoL in IDDM 
Tahbaz, Kreis and Calvert (2006) state that some studies indicate that people with IDDM 
have the same QoL as those without the condition, whilst other studies suggest that people 
with IDDM have a poorer quality of life than the general population, but not as poor as that 
experienced by others with a chronic health condition. It is acknowledged that those with 
IDDM are likely to die earlier than those without it (NICE, 2015). People with IDDM are 
vulnerable to painful and debilitating complications and other illnesses, they may experience 
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stigma, or a sense that they have lost their independence and freedom (NICE, 2015). 
Furthermore, people with IDDM may experience poor self-image, IDDM may impact upon 
their relationships, and they may experience economic disadvantage, poor education and poor 
social support (Tahbaz et al., 2006).  
A variety of factors have been evidenced to influence QoL in people who have been 
diagnosed with diabetes. Rose, Fliege, Hildebrandt, Schirop and Klapp (2002) indicated that 
age, complications, related illnesses, family support, marital relationships, poverty and 
education all influence quality of life. Other factors that have also been found to influence 
QoL include the clinic environment, the doctor, the relationship between doctor and patient, 
patient personality, coping and characteristics of the illness (Rose et al., 2002). 
Rubin and Peyrot (1999) reviewed QoL in diabetes studies, proposing that published 
results have generally indicated that better glycaemic control ‘occurs alongside’ better QoL, 
particularly as the burden of a strict treatment regimen may offset debilitating and painful 
complications that would inevitably impact upon QoL. This is the argument proposed by the 
DCCT (1993); however, the research cited by Rubin and Peyrot (1999) mainly uses 
participants with Type 2 diabetes. Two of the studies with IDDM involve adolescents. Braga 
De Souza et al. (2015) states that the majority of the research undertaken is with people 
diagnosed with Type 2 diabetes, or with mixed samples. 
QoL measures in IDDM 
Speight et al. (2009) reviewed the use of QoL measures with the diabetic population.  The 
authors aimed to provide clarity regarding the conceptualisation of QoL, terminology, and 
psychometric properties of the measures, and to review the measures and offer 
recommendations as ‘QoL’ is often ambiguous and misunderstood. There is little agreement 
about what ‘QoL’ is, the key components, and how it should be defined and measured. 
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Of the tools available to measure QoL in quantitative research, Speight et al. (2009) 
argued that only three of the ten most commonly used tools in research actually measure 
QoL. These were: the World Health Organisation Quality of Life Scale (WHOQoL; WHO, 
1997), Diabetes Related Quality of Life (DRQoL; Jacobson, 1994) and the Audit of Diabetes 
Dependent Quality of Life (ADDQoL; Bradley et al., 1999). They proposed that other, 
widely used measures, more accurately capture general physical health status, such as the SF-
36 (Ware & Sherbourne, 1992) and the EURO-QoL (EURO QoL Group, 1990). Other 
measures focus upon psychological well-being, such as the Hospital Anxiety and Depression 
Scale (Zigmond & Snaith, 1983), Well-Being Questionnaire (Bradley, 1994) or the Problem 
Areas in Diabetes Scale (PAID; Polonsky et al., 1995). Speight et al. (2009) argued that if the 
measures are inappropriately selected, then data may be misinterpreted and any conclusions 
drawn will be fundamentally flawed. 
Rubin and Peyrot (1999) proposed that if generic measures had been used in a study, they 
would have been less sensitive to QoL than diabetes-specific QoL measures. Speight et al. 
(2009) explored this in greater depth in their more recent review of measures, discussing the 
strengths and limitations of both generic and diabetes-specific tools and concluding that the 
measure must be fit for purpose in light of the research question.  
The relationship between HbA1c and QoL 
Wikblad, Leksell and Wibell (1996) indicated that focusing on HbA1c fails to effectively 
capture the impact of hypoglycaemic episodes that may impact upon QoL. In this respect it 
may be that the condition could be over-managed and the low HbA1c may impact upon QoL. 
Therefore, the relationship between HbA1c and QoL is subject to debate (Camacho, 
Anderson & Bell, 2002). It is not clear if achieving a near normal HbA1c is associated with 
an improved or diminished QoL for people with IDDM.  
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Summary and rationale for the review 
IDDM is a chronic condition that typically develops in childhood. It requires careful 
management to minimise the risk of short, medium and long-term complications. Evidence 
indicates that achieving a near normal HbA1c reduces the risk of complications and this 
informs current healthcare policy. However, it is yet to be established how striving to achieve 
a near normal HbA1c relates to QoL. It appears that research in this area is compromised by a 
lack of clarity regarding QoL and the various tools used to measure it. The extant literature is 
dominated by research with participants with Type 2 diabetes or a wide age range.  
An understanding of the relationship between QoL and HbA1c may have implications for 
healthcare services and the anecdotal assumption that a near normal HbA1c relates to good 
QoL. The aim of this systematic review therefore is to review the evidence regarding the 
relationship between HbA1c and quality of life in adults with IDDM.  
 
Method 
Study identification and search terms 
The Preferred Method for Reporting Systematic Reviews and Meta Analyses (PRISMA; 
Moher, Liberati, Tetzlaff & Altman, 2009) guidelines were followed in the search strategy 
and reporting of this review (see Figure 1). 
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Figure 1. PRISMA flow diagram.  
 
335 records after duplicates removed 
335 Titles and abstracts screened 
31 full text articles excluded 
5 merged data for both Type 1 and Type 2 diabetes 
2 did not include a measure of quality of life 
7 did not report the relationship between QoL and 
HbA1c 
12 reported the relationship as part of an intervention 
4 used participants younger than 18 
1 was a literature review 
 
38 Full text articles assessed for 
eligibility 
38 
297 records excluded 
7 Studies included in the systematic 
review 
333 articles identified 
Total number of articles identified 338 
 
5 Additional articles identified 
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An extensive literature search was undertaken following a series of scoping searches and 
advice from local experts and a specialist librarian.  The electronic databases CINAHL 
(1937-current), MEDLINE (1949-current), PsycARTICLES (1894-current) and PsycINFO 
(1887-current) were searched using the platform EBSCO. The searches at this stage were 
undertaken solely by the main researcher.  The search was conducted using the following 
terms: HbA1c OR glycaemic control OR glycemic control OR metabolic control AND 
quality of life OR health related quality of life AND Type 1 diabetes OR IDDM OR insulin 
dependent diabetes AND Adults. The search was undertaken October 2016 and updated 
March 2017. 
Eligibility criteria 
The following criteria were used to identify potential studies: Quantitative studies; 
full text available in English; adults over the age of 18; diagnosed with IDDM; using a 
standardised self-report measure of QoL and reported HbA1c (self-report or from medical 
records); and analysed via correlation or regression analyses. The following exclusion criteria 
were used: Qualitative studies; studies involving children and adolescents; studies exploring 
multiple physical health problems, for example diabetes, obesity, high blood pressure and 
other conditions; randomised control trials and studies measuring the effectiveness of an 
intervention. Table 1 summarises the main characteristics of the seven studies selected for 
review and provides details of the authors, year of publication and country, the primary focus 
of the article, sample characteristics, the design, methodology, measurement tools, outcomes 
and quality rating. The studies are in alphabetical order.   
Assessment of quality 
Study quality was assessed using the 16 item Quality Assessment Tool for Studies 
with Diverse Designs (QATSDD; Sirriyeh, Lawton, Gardner & Armitage, 2011); therefore, 
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all of the studies could be appraised using one tool. Sirriyeh et al. (2011) developed the tool 
after reviewing the many tools that are available, and in this respect it appears comprehensive 
and helps structure the quality appraisal. Two of the items (interview procedure and 
qualitative analysis) were omitted as they were only applicable to qualitative studies. Each 
item was scored between 0 and 3 depending on if they met the criteria (0 = not met, 1 = very 
slightly met, 2 = moderately met & 3 = completely met) and each paper was given an overall 
quality rating. The higher the score, the higher the quality of the research. The tool provided 
guidance on how to score each item, and in order to increase reliability, a second, 
independent reviewer (D.Clin.Psy trainee colleague) also undertook the quality assessment. 
The results of the QATSDD quality appraisal are summarised in Table 2 below. 
Data abstraction and synthesis 
None of the studies used the same QoL measure. The measures varied in their 
measurement of QoL; some focused on health-related QoL whilst others focused upon 
physical health or QoL more broadly. The analyses also varied from correlation to regression 
analysis. In this respect, the findings were considered unsuitable for meta-analysis.  
 
Results 
Search results 
The electronic search identified 335 records after duplicates were excluded. The titles and 
abstracts were screened by the main author and a further 297 articles were deemed to be 
unsuitable for inclusion. The main reasons for exclusion were mixed samples of IDDM and 
Type 2 diabetes, mixed samples of young people and adults, reported as part of a trial or 
intervention, and not reporting the correlation or regression. Thirty-eight full text articles 
were obtained. The main author reviewed each article and excluded a further 31 papers. 
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Assistance was sought via an independent reviewer (D.Clin.Psy trainee colleague) or expert 
advice, where it was unclear if an article fully met the inclusion criteria or if it should be 
excluded. The article selection process and the reasons that articles were excluded are 
illustrated in Figure 1. The following seven papers fulfilled the criteria for inclusion: Aalto, 
Uutela and Aro (1997); Gawlik, Elias and Bond (2015); Hendricks, Monaghan, Soutor, Chen 
and Holmes (2013); McQueen et al. (2014); Strandberg, Graue, Wentzel-Larsen, Petrot and 
Rokne (2014); Wikblad, Leksell and Wibell (1996); and Wikby, Hornquist, Stenstrom and 
Andersson (1993). 
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Table 1  
A summary  of the design and outcomes for each of the studies                  
 
First author 
Country 
Year of 
publication 
Primary focus of 
article 
Sample 
charact-
eristics 
Control group Age Design Data collection 
methodology 
Measurement tools Reported outcomes Quality 
rating 
          
Aalto, Uutela and 
Aro 
Finland 
1997 
Health and 
psychosocial 
correlates of health 
related quality of 
life  
385 Adults N/A 20-64 
(range). 
Mean age 
33 (SD 
8.9). 
Cross 
sectional  
Self-report 
Questionnaires. 
 
MOS-SF 20 health 
survey and 
HbA1c. 
No overall relationship between quality of life and 
HbA1c. 
Significant associations were found between 
metabolic control and role functioning (X = 7.02, df = 
2, P < 0.05). Problems in role functioning were 
reported more often among those in poor control 
(17%) and tight control (13%) than among those in 
moderate control (5%). 
 
57% 
Gawlik, Elias and 
Bond. 
Adelaide, 
Australia 
2015 
 
 
 
 
 
 
 
 
To explore the 
relationships 
between body 
image, QoL, 
HbA1c and insulin 
restriction as a 
weight control 
strategy  
177 Adult 
Women 
N/A 18-68 
(range). 
Mean age 
36.32 (SD 
11.33). 
Cross 
sectional 
Self-report 
questionnaires and 
participants self-
reported their most 
recent HbA1c 
result. 
Appearance 
Schemas 
Inventory; 
Diabetes Quality 
of Life Brief 
Clinical Inventory 
and HbA1c. 
A negative correlation between QoL and HbA1c     
r=-.30, P<.001. 
Further analysis identified that the relationship was 
best described as curve-linear. A one-way ANOVA 
between categories: low, ideal, somewhat high and 
very high: Low (n=24) mean (SD) = 53.00 (8.13), 
Ideal (n=31) mean (SD) = 54.17 (8.07), somewhat 
high (n=62) mean (SD) 53.44 (8.15) and very high 
(n=52) mean (SD) 46.59 (8.65) = F linear 9.64** = F 
quadratic 10.77*** = n2=.058.  
**P≤.01. *** P≤.001. 
59.5% 
Hendricks, 
Monaghan, 
Soutor, Chen and 
Holmes. 
Baltimore, USA 
2013 
 
To explore the 
relationship 
between daily self-
care behaviors and 
psychosocial 
adjustment and 
HbA1c 
49 
‘emerging 
adults’ 
N/A 18-26 
(range). 
Mean age 
20.6. (SD 
1.9). 
Cross 
sectional 
Interviews and self-
report 
questionnaires. 
HbA1c was 
measured via blood 
sample. 
24 hour diabetes 
interview; The 
Brief Symptom 
Inventory; The 
Diabetes Quality 
of Life Measure; 
HbA1c 
There was no correlation between QoL and HbA1c; 
however, better psychological well-being on the Brief 
Symptom Inventory correlated with more favourable 
diabetes quality of life on the Diabetes Quality of life 
Measure, r=-0.33, P<.05. 
 
 
 
 
62% 
McQueen, Ellis, 
Maahs, 
Anderson, Nair, 
Libby  
and Campbell. 
Switzerland 
2014   
To explore the 
relationship 
between HbA1c 
and health utility 
176 Adults N/A Mean age 
38 (SD 
12.2). 
Cross 
sectional  
Self-report 
questionnaires and 
HbA1c was 
obtained from 
medical records. 
Diabetes related 
complications; 
duration of 
diabetes; Euro-
QOL and HbA1c. 
Negative correlation: After adjusting for 
demographics, medications, and diabetes related 
complications, on average, a 1% point increase in 
HbA1c was associated with a disutility of -0.03 (95% 
confidence interval -0.049, -0.006) P<.05.  
 
 
 
69% 
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Strandberg, 
Graue, 
Wentzel-Larsen, 
Peyrot 
and Rokne.  
Norway 
2014 
 
To explore the 
relationships 
between diabetes 
specific emotional 
distress, depression, 
anxiety, and overall 
well-being with 
HbA1c in adults 
with type 1 diabetes 
235 Adults  
185 (after 
exclusions 
for missing 
data) 
Comparison 
with non-
responden-ts. 
No significant 
difference in 
terms of sex, 
age and HbA1c. 
18-69 
(range). 
Mean age 
39 (SD 
13.7). 
 
Cross 
sectional 
Self-report 
questionnaires. 
HbA1c measured 
via blood sample 
HbA1c. Diabetes 
Distress Scale 
(DDS); The 
Problem Area in 
Diabetes Survey 
(PAID); The 
Hospital Anxiety 
and Depression 
Scale (HADS); the 
World Health 
Organization- Five 
well-being Index 
(WHO-5). 
Mixed results: 
PAID and DDS total scores (unstandardized 
coefficient 0.020, P =.001, and 0.033, P <.001 
respectively) and regimen related distress subscale 
(DDS) and emotional burden subscale (DDS) (0.039, 
P <.001, and 0.014, P = .005 respectively) were 
significantly related to HbA1c. HADS anxiety, 
HADS depression and WHO-5 were not significantly 
related to HbA1c.  
 
 
 
 
 
52% 
          
Wikblad, Leksell 
and 
Wibell 
Sweden 
1996 
 
To explore HbA1c, 
late complications 
and quality of life 
108 Adults Unclear 
comparison 
with non-
respondents 
Mean age 
43.5 (SD 
5.7). 
Cohort study Self-report 
questionnaires. 
HbA1c mean value 
in one year 
calculated via blood 
samples 
 
HbA1C, 
SWEDQOL, 
number of 
hypoglycemic 
events, late 
complications, 
duration of 
diabetes and age. 
Curve linear relationship: When HRQOL was 
compared among patients with different levels of 
metabolic control, those with acceptable metabolic 
control had the highest rating on most scales (no 
statistical analysis available). People who reported 
hypoglycemic episodes rated their general health as 
being poorer compared with those without 
hypoglycemic episodes (57.7, SD 9.2 Vs 74.9 SD 
3.2; F =4.2, P =0.04). They proposed that a curve 
linear relationship existed between Quality of life and 
HbA1c, and that poor metabolic control was related 
to poorer physical and emotional health.  
 
 
45% 
Wikby, 
Hornquist, 
Stenstrom and 
Andersson 
Switzerland 
1993 
 
To explore the 
factors related to 
health-related 
quality of life: 
demographic and 
social factors,  
complications and 
metabolic control 
66 Adults  N/A Mean age 
42.6 (SD 
14). 
Cohort study Self-report 
questionnaires. 
Does not state how 
HbA1c obtained. 
Quality of life 
composite score 
and scaled scores 
for: illness, 
somatic health, 
psychological, 
social, 
behavioural, habits 
and global life 
satisfaction.  
No overall relationship between quality of life and 
HbA1c. 
HbA1c was associated with the subscale of somatic 
health but no other QoL scales (r=-0.34, P<.005.) 
 
 
 
57% 
 
Table 1 summarises the main characteristics of the seven studies selected for review.  
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Table 2. 
Quality assessment ratings for the selected seven studies  
Quality criteria Study 
One 
 
Aalto 
1997 
Study 
Two 
 
Gawlik 
2015 
Study 
Three 
 
Hendricks 
2013 
Study 
Four 
 
McQueen 
2014 
Study 
Five 
 
Standberg 
2014 
Study  
Six 
 
Wikblad  
1996 
Study  
Seven 
 
Wikby 
1993 
        
Explicit theoretical framework  
 
2 2 2 2 2 2 3 
Statement of aim/objectives in main body of report 2 3 2 3 2 3  2 
Clear description of research setting 2 3 3 3 1 2 2 
Evidence of sample size 0 0 0 3 0 0 2 
Representative sample of target group of a reasonable size 3 2 2 2 1 1 1 
Description of procedure for data collection 1 1 3 2 1 1 2 
Rationale for choice of data collection tools 1  2 2 2 2 1 2 
Detailed recruitment data 2 1 2 2 2 2 0 
Statistical assessment of reliability and validity of measurement tools  2 3 3 0 3 2 2 
Fit between stated research questions and method of data collection  3 3 3 3 2 2 3 
Fit between research questions and method of analysis 
 
2 2 2 3 2 2 2 
Good justification for analytical method section  2 1 1 2 2 1 2 
Evidence of user involvement 0 0 0 0 0 0 0 
Strengths and limitations critically discussed  2 2 1 2 2 0 1 
Total quality rating (out of 42)  24 = 57% 25 = 
59.5% 
26 = 62% 29 = 69% 22 = 52% 19 = 45% 24 = 57% 
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Table 2 details the individual quality assessment for each study using the 16 item 
Quality Assessment Tool for Studies with Diverse Designs (QATSDD; Sirriyeh et al., 2011). 
Country of origin, design and focus of research  
None of the research was undertaken in the UK and this may have implications for the 
generalisability of any results. The studies were carried out in the USA, Australia, Finland, 
Sweden, Norway and two in Switzerland. Three studies were undertaken in the 1990s (1993, 
1996 and 1997), and the remainder were undertaken more recently (2013, two in 2014 and 
2015). They were mostly cross-sectional in design whilst two were cohort studies. In most 
cases the research aimed to explore the relationships between many variables, in addition to 
the two variables the present review focused upon (HbA1c and QoL). For example, 
Hendricks et al. (2013) explored the relationships between a range of self-care behaviours, 
psychosocial adjustment and HbA1c. A further example is Gawlik et al. (2015), who 
explored body image and insulin restriction as a weight control strategy, in addition to QoL 
and HbA1c. Only one study focused upon the relationship between HbA1c and ‘health 
utility’ (McQueen et al., 2014). This was heavily weighted towards the physical health 
construct of QoL and its aim was to explore cost effectiveness.   
Participant characteristics  
The sample sizes varied from 49 to 385. Participants were mostly recruited from 
specialist diabetic clinics or centres. One of the studies specifically targeted emerging adults 
whilst another included women only, which may have implications for the generalisability of 
the findings, although the remainder focused more broadly upon adults.  Two studies had 
control groups; one compared basic details between respondents and non-respondents 
whereas the other did not provide details about the control group.   
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Measures  
The studies used self-report questionnaires to measure QoL. Some of these tools had 
been specifically developed to measure QoL in diabetes (DQoL; Jacobson, 1994 & DQoL 
Brief Clinical Inventory; Burroughs, Desikan, Waterman, Gilin & McGill, 2004), two 
measures focused upon health-related QoL (MOS-SF; Steward, Hays & Ware, 1988 & 
EURO-QoL; EURO QoL Group, 1990), two measured QoL more broadly (SWEDQoL; 
Brorsson, Ifver, Hays, 1993 & WHO-5; Bech, Olsen, Kjoller & Rasmssen, 2003). Wikby et 
al. (1993) used a measure that had been designed and used previously by one of the authors 
(Hanestad, Hornquist & Albrektsen, 1991). Therefore, the self-report measures used varied in 
their focus, from diabetes-related QoL, health-related QoL or simply QoL. They also varied 
in how comprehensive they were, with two of the measures asking only five questions; for 
example, McQueen et al. (2014) used the EURO-QoL and did not report a measure of 
internal reliability (Cronbach’s alpha).  All of the other studies reported the Cronbach’s alpha 
of the measures used, and these varied from 0.77 to 0.93. No studies used the same measure. 
Whilst it is generally accepted that HbA1c is a universally agreed measure, the means 
for obtaining this result also varied between studies. For example, some used medical records 
to obtain a single result or an average from the previous 12 months, some used a single blood 
test, some used more than one blood test to obtain an average, some self-reported their most 
recent result and some used a ‘home testing kit’. Only three studies stated if their equipment 
was calibrated to an agreed standard.  
Analysis 
The studies were analysed using correlation or regression analyses to explore the 
relationships between the various variables.  
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Outcome: No relationship between HbA1c and overall QoL 
Hendricks et al. (2013) proposed that psychological well-being and QoL were not 
significantly correlated with HbA1c. The study used a small sample (N=49) of emerging 
adults (18-26 years of age) and measured HbA1c on a single occasion. Whilst there was no 
evidence of an overall relationship between QoL and HbA1c, the authors identified that better 
psychological well-being on the Brief Symptom Inventory (Derogatis & Melisaratos, 1983) 
correlated with more favourable diabetes QoL on the Diabetes Quality of Life Measure 
(DQOL; Jacobson, 1994), r = -0.33, P<.05. This may demonstrate that better psychological 
well-being occurs alongside better QoL, as measured by the DQoL. 
Wikby et al. (1993) also identified that there was no correlation between HbA1c and 
QoL. They used a measure that had been designed and previously used by one of the authors 
(Hanestad et al., 1991). The measure explored seven domains: illness, somatic health, 
psychological, social, behaviour and activity, habits and global life satisfaction. HbA1c was 
only associated with the somatic health subscale of QoL but none of the other subscales (r = -
0.34, P<.005.). Therefore, perceived somatic health was positively associated with greater 
metabolic control, meaning the greater the perceived somatic health, the greater the metabolic 
control (and therefore, the lower the HbA1c). This study also used a small number (N=66) of 
adults, although the sample was general adults, with a mean age of 42.6 years. It is not 
indicated how HbA1c was obtained. 
Aalto et al. (1997) failed to identify a relationship between HbA1c and health-related 
QoL as measured by the MOS 20 SF (Steward et al., 1988). The measure conceptualises QoL 
via assessing the domains of physical functioning, role functioning, social functioning, 
mental health and lack of pain. Whilst no overall relationship was identified between HbA1c 
and QoL, the authors identified a relationship between HbA1c and a domain of QoL, namely 
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role functioning (X = 7.02, df = 2, P < 0.05). Role functioning was defined as limitations in 
performing one’s usual role due to poor health. The authors noted that problems in role 
functioning were reported more often among those with poor control (17%) and tight control 
(13%) than among those with moderate control (5%). This indicated that role functioning is 
an important component of QoL and that this effect was more marked for those with poor 
control and tight control. It is important to note that the role functioning subscale contains 
only two questions. The study used a larger sample of 385 adults with a mean age of 33.  
Outcome: Mixed results 
Strandberg et al. (2014) offered mixed results. They were unable to find a correlation 
between HbA1c and well-being (WHO 5 well-being), or anxiety and depression (HADS; 
Zigmond & Snaith, 1983); however, they identified a positive correlation between HbA1c 
and diabetes-related distress. The authors concluded that Problem Areas In Diabetes (PAID; 
Welch et al., 1995) and Diabetes Distress Scale (DDS; Polonsky et al., 2005) total scores 
(unstandardized coefficient 0.020, P =.001, and 0.033, P <.001 respectively) and regimen 
related distress subscale (DDS) and emotional burden subscale (DDS) (0.039, P <.001, and 
0.014, P = .005 respectively) were significantly related to HbA1c. As HbA1c increased, the 
following increased: PAID score, DDS score, regimen-related distress and emotional burden. 
This indicated that distress related to diabetes, particularly concerning the emotional impact 
and regimen-related distress, were related to HbA1c whilst anxiety, depression and overall 
well-being were not. This study started with a sample of 235, but this was reduced to 185 
after exclusions for missing data. It used a comparison group and there were no significant 
differences between respondents and non-respondents regarding sex, age and HbA1c. 
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Outcome: Negative correlation  
McQueen et al. (2014) proposed that after adjusting for demographics, medications, 
and diabetes related complications, an increase in HbA1c was associated with an increase in 
health disutility. This cost effectiveness study used health utilities (measured by the EURO 
QoL) and costs over time to calculate the long term quality adjusted life years (QALYs) and 
costs. Health utility reflects the state of living in a healthy state with diabetes. Health 
disutility is a term used to define the difference between the IDDM population and the 
general population. Both terms are used alongside QALYs in cost effectiveness models to 
calculate disability and costs associated with health conditions and interventions. Whilst the 
main aim of this study was to explore cost effectiveness, it indicated a clear negative 
correlation between HbA1c and ‘health utility’, or health related QoL as measured by the 
EURO-QoL. Therefore, as HbA1c increased, health related QoL decreased. The authors used 
a sample of 176 adults with a mean age of 38 years. This study scored the highest in the 
quality rating with a percentage of 69; however, whilst HbA1c was taken from medical 
records, QoL was measured using the five question EURO-QoL that purports to measure 
general physical health status. The EURO-QoL has only 5 items, these  are very basic and 
therefore, it is a crude instruments for measuring QoL compared to studies with a lower % 
quality rating that used more sensitive measures. 
Outcome: Curve-linear correlation  
Wikblad et al. (1996) argued that a curve-linear relationship existed between QoL and 
HbA1c. When health-related QoL was compared among patients with different levels of 
metabolic control (good HbA1c <7%, acceptable HbA1c 7.1-8%, unacceptable 8.1-9% and 
unsatisfactory >9%), those with acceptable metabolic control (HbA1c 7.1-8%) had the 
highest rating on the subscales of the SWEDQUAL (Brorsson et al., 1993), including 
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physical functioning, mobility, satisfaction with physical health, role limitation due to 
physical health, pain, positive feelings, negative feelings, role limitations due to emotional 
health, sleep problems, satisfaction with family life, marital functioning, sexual functioning 
and general health. Wikblad et al. (1996) fail to offer any statistical analysis to support their 
assertion that those with acceptable metabolic control reported the greatest QoL, although 
this is demonstrated pictorially in a graph in the paper. This paper had the lowest scoring 
quality rating of 45%. The authors acknowledged that HbA1c may be misleading as it fails to 
capture the number of hypoglycaemic events people may experience. Statistical analysis was 
available regarding participants who reported hypoglycaemic episodes, who rated their 
general health as being poorer compared to those without hypoglycaemic episodes (57.7, SD 
9.2 Vs 74.9 SD 3.2; F =4.2, P =0.04). The authors proposed that a curve-linear relationship 
exists between QoL and HbA1c, meaning that those with an ‘acceptable’ HbA1c of between 
7.1% and 8% report the greatest QoL, and that both low and high HbA1c are related to lower 
QoL. 
Gawlik et al. (2015) initially identified a significant negative correlation between QoL 
(Diabetes Quality of Life Brief Clinical Inventory; Burroughs et al., 2004) and HbA1c: r=-
.30, P<.001. However, they investigated further as they believed that a curve-linear 
relationship may better describe their data. They undertook a one-way ANOVA using the 
categories of low, ideal, somewhat high and very high; they identified a highly significant 
result with a medium effect size. This study included only women and focused upon body 
image, insulin restriction as a weight control strategy and HbA1c. The study used a diabetes-
specific QoL measure (Diabetes Quality of Life Brief Clinical Inventory; Burroughs et al., 
2004); however, participants self-reported their most recent HbA1c result.   
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Discussion 
Theoretical framework 
Only one of the seven studies explored QoL as a theoretical construct (Wikby et al., 
1993); therefore, the studies could be seen as theoretically weak. This may have been because 
the focus of the articles varied. For example, whilst all of the articles included HbA1c and a 
measure of QoL or well-being, the focus varied from self-care behaviours and adjustment, 
body image and insulin as a weight control strategy, psychosocial factors, social factors, 
complications and cost effectiveness.  Whilst the studies described the theory relevant to their 
focus, they failed to conceptualise QoL. This has implications for the present review and is in 
keeping with Speight et al.’s (2009) findings, who state that there are inherent difficulties 
when investigating a subjective, dynamic and multi-dimensional concept such as QoL. 
Therefore, it is imperative that studies clearly indicate their understanding of QoL.  This is 
discussed further in relation to measures and problems, i.e. whether the measure focused 
upon health related QoL, diabetes-related QoL or generic QoL. 
Strengths and limitations 
Aims, participants, recruitment and sample size 
A relative strength of each of the studies concerned their explicitly stated aims and 
objectives, as well as a detailed description of the research setting. Very few provided 
sufficient detail regarding participant recruitment. Only one of the studies (McQueen et al., 
2014) considered sample size and indicated a minimum sample size, although they did not 
indicate how they calculated statistical power. Sample size varied, for example one study had 
a sample size of 49 (Hendricks et al., 2013) whilst another had 66 (Wikby, et al., 1993), the 
remainder had between 100 and 300 participants. Two of the seven studies were concerned 
with particular samples: Hendricks et al. (2013) focused upon emerging adults whilst Gawlik 
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et al. (2015) included only women.  Both studies provided a rationale for their respective 
sampling strategy, although this may have had implications for the generalisability of such 
results. 
Data collection and rationale for data collection tools 
Only one of the studies scored the maximum for detailing the procedure for data 
collection (Hendricks et al., 2013), which has implications for reliability and the ability to 
replicate the studies. No studies scored the maximum for offering a rationale for the data 
collection tools. This was a significant flaw in all the studies, particularly in light of the 
findings of Speight et al. (2009) and the lack of a theoretical framework.  
Reliability and validity of tools 
A strength of the studies was that most offered statistical assessment of the measures 
used; however, this is of little value if the measures were incorrectly employed. It is 
important to note that the measures of QoL were all self-report measures and no two studies 
used the same measure. It could be argued that some purported to measure QoL but may 
more accurately have assessed physical health status. This means that synthesis of the results 
from the papers is difficult. The lack of a theoretical framework and poor justification of the 
tools used to measure QoL is in keeping with the earlier criticisms proposed by Speight et al. 
(2009).  
HbA1c was typically measured via a blood sample on one occasion, some accessed 
medical records and calculated a mean HbA1c result throughout the past 12 months, some 
used a single blood test, one used a ‘HbA1c now kit’ whilst another asked participants to self-
report their last HbA1c result.  
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Goodness of fit between research question and analysis 
There was generally a good fit between the stated research questions and data collection 
(or measurement); although this had to be inferred and was not explicitly discussed. The 
research undertaken was typically cross-sectional and used to explore the relationship 
between a number of variables, which has implications for inferring causality or gaining a 
deeper understanding of the direction of potential relationships.   
Justification of analysis 
The analysis was a relative strength of all of the studies as this suited the design of the 
studies; although (as above) correlation or regression analysis means that one cannot infer 
causality. Furthermore, correlation is based upon the assumption of the general linear model 
and this may not accurately capture the relationship between the two variables in question. 
Gawlik et al. (2015) undertook a one-way ANOVA using the categories of low, ideal, 
somewhat high and very high to identify a curve-linear relationship. If QoL is understood as a 
subjective concept that is multi-dimensional, dynamic and influenced by numerous, 
interrelated factors that change over time, an alternative research methodology may allow for 
more flexibility in exploring such relationships.  
User involvement and discussion of strengths and limitations 
A major limitation of all of the studies was that they did not have any involvement from 
service users.  Only one study scored the maximum for discussing both the strengths and 
limitations to their research. 
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Summary of quality and quality assessment tool 
The aims of the studies and research setting were generally clear; although the focus of 
the studies varied and only one focused specifically upon HbA1c and QoL (the emphasis was 
upon demonstrating cost effectiveness, and it used the EURO-QoL that focuses upon physical 
health). All but one of the articles failed to explicitly discuss and define QoL. This is a major 
limitation, exacerbated by the use of inappropriate tools that purport to measure QoL, and the 
absence of any rationale for their use, although most used a measure of validity. No studies 
used the same measure, indicating the diverse measures available. The measures of QoL were 
all self-reported and some placed greater emphasis on physical health. Studies varied in how 
they obtained an HbA1c value. Few studies considered sample size and the size varied 
between studies. Two targeted a specific sample and there was inadequate detail regarding 
recruitment procedures. Most studies were cross-sectional and this has implications for 
inferring causality. There appeared an overall fit between question, data collection and 
method of analysis but there was poor justification of the analysis. All seven studies were 
weak regarding service user involvement and discussion of strengths and limitations. 
The 16 item Quality Assessment Tool for Studies with Diverse Designs (QATSDD; 
Sirriyeh et al., 2011) helped to structure and guide the critical appraisal of each study. Whilst 
the tool provides an overall quality rating, this can be misleading, as it does not specify the 
individual strengths or weaknesses of each study. An example of this is the McQueen et al. 
(2014) study that scored the highest for quality, despite it using a brief measure of QoL that 
focused upon physical health (EURO-QoL). 
Summary of outcomes  
Three of the seven studies did not identify a relationship between QoL and HbA1c; 
although some studies identified relationships between the subscales of somatic health 
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(Wikby et al., 1993) and role functioning (Aalto, 1997). Whilst there may have been no 
significant relationship identified with QoL overall, there were relationships with some of the 
subscales. Strandberg et al. (2014) offered mixed results; there were no correlations identified 
between HbA1c and well-being, anxiety or depression. However, the Problem Areas in 
Diabetes Scale (PAID; Polonsky et al., 1995) and the Diabetes Distress Scale (DDS; 
Polonsky et al., 2005) were related to a higher HbA1c.  
McQueen et al. (2014) identified a negative correlation between QoL and HbA1c. 
Whilst this was a robust piece of research, the authors used the EURO-QoL and it has been 
argued that this is a crude measure that focuses upon general physical health. Wikblad (1996) 
and Gawlik (2015) proposed a curve linear relationship. Wikblad’s (1996) analysis was poor, 
although they considered the impact of hypoglycaemic events and their argument makes 
intuitive sense. Gawlik (2015) focused upon women specifically with self-reported HbA1c, 
but the study used a diabetes specific QoL measure. 
Limitations and strengths of the present review  
This systematic review could have been strengthened by employing another 
researcher to independently screen the titles and abstracts using the given search terms. The 
full-text articles could then also have been independently reviewed to ensure no articles were 
excluded by mistake. Even though a quality tool was used, the review was still vulnerable to 
bias through lack of independent verification. 
However, careful attention was given to search terms and assistance was sought via 
local experts and a specialist librarian. Where there was doubt regarding excluding a study, 
an independent member of the University research team was consulted. All seven of the 
included studies were independently quality assessed.  
 
30 
 
Conclusion 
Three studies indicated that a relationship between HbA1c and QoL could not be 
identified. One study offered mixed results. A further study identified that a negative 
correlation existed: as HbA1c increased QoL (general health status) decreased. Two studies 
proposed that a curve-linear relationship existed: those people with acceptable control had the 
best QoL whilst those with low HbA1c and high HbA1c reported poorer QoL. Given the 
findings, it is difficult to provide a conclusive statement regarding the relationship between 
QoL and HbA1c.  
Current healthcare policy focuses on achieving a near normal range for HbA1c to lower 
the risk of associated complications (NICE, 2015). The impact of this on QoL remains 
unclear. Whilst achieving the required target for HbA1c may lower the risk of physical 
complications and subsequent deterioration in QoL in the long-term, it may be that more 
attention needs to be given to QoL in the short-term, particularly regarding the psychological, 
emotional and social needs of those with IDDM. This may be particularly salient for some 
groups, for example adolescents or young adults.  
None of the studies set out to specifically explore the relationship between HbA1c and 
QoL. The research included in this review is generally of a poor quality. The main reasons for 
this are that few explored the theoretical construct of QoL and there was little rationale to 
justify the use of measures (all QoL measures were self-reported). Some of the measures 
(EURO-QoL and MoS 20 SF) more accurately assessed physical health status (Speight et al., 
2009). Sample size varied, some targeted specific samples, and none of the research was 
undertaken in the UK. The studies largely captured a cross section of participants and this, as 
well as the correlational analysis, meant that one is unable to infer causality. It could be 
argued that such a design and analysis fails to capture the complexity of the relationship 
between HbA1c and QoL. None of the research involved service users themselves, who may 
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be key to guiding future research, particularly if future research employed a different 
methodology.   
Further research 
There is an urgent need for a well-designed study to further explore the relationship 
between HbA1c and QoL. Particular attention needs to be given to the limitations that exist in 
the current research, for example a lack of clear theoretical constructs and appropriate 
measures, and limitations of cross-sectional studies and correlational analyses. Robust, 
quantitative, longitudinal research might be able to generate more reliable results and allow 
for conclusions regarding causality to be drawn. 
In addition, there are inherent problems when investigating QoL using quantitative 
methodology. Future research could employ a qualitative approach to gain a rich 
understanding of people with IDDM and their experiences of QoL, what it means to them and 
how they manage to live well with IDDM. This may help to explore the complex relationship 
between HbA1c and QoL and provide a useful insight into how people manage to live well 
with a chronic health condition. This may be particularly salient in an adolescent population. 
The onset of IDDM often occurs in childhood and four out of five adolescents are unable to 
achieve the advised target for glycaemic control (Spencer, Cooper & Milton, 2010). It may 
prove fruitful to take a positive psychology approach and explore with adolescents 
themselves how they manage to ‘live well’ with IDDM. 
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Abstract 
Objectives: This qualitative study explored how adolescents aged 13 to 19 with insulin-
dependent diabetes (IDDM) experience themselves as able to ‘live well’ despite their chronic 
condition.  
Design: Qualitative.  
Methods: Data were gathered through face-to-face semi-structured interviews, with a 
purposive sample of eight adolescents, aged 13-19, who self-identified as living well with 
IDDM.   
Results: Interpretative Phenomenological Analysis (IPA) identified the following four main 
themes: Emotional security in and from close personal relationships, The journey from denial 
and avoidance to acceptance and control, “Living a normal life: Doing the same things that 
other kids do” and Psychological resilience: The importance of a positive mind-set. Each 
theme had between four and six subthemes.  
Conclusions: Participants wanted a ‘normal’ life and each individual had their own 
subjective view of living well. Living well occurred in the context of close personal 
relationships. Adjustment and adolescent development were reviewed with particular 
emphasis on identity and coping. Participants expressed a number of seemingly paradoxical 
statements and had a range of personal characteristics that promoted living well; they were 
psychologically resilient and had a range of support available. 
Key words: Type 1 Insulin-Dependent Diabetes Mellitus, Adolescence, ‘Living well’, Quality 
of Life, Psychological wellbeing 
This article will be submitted to the British Journal of Health Psychology. Maximum word 
count 6,000 (Appendix 1). Word count: 5,998.  
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Introduction 
Insulin-Dependent Diabetes Mellitus (IDDM) is one of the most common chronic 
childhood conditions in the UK, affecting one adolescent per 550. The peak age for diagnosis 
is between 10-14 years (Department of Health; DoH, 2007). IDDM is a chronic condition that 
requires careful management to reduce the risk of severe, life-changing consequences (The 
Diabetes Control and Complication Trial; DCCT, 1993). Aiming to achieve a near normal 
glycaemic range lowers the risk of such complications, and this finding has informed UK 
healthcare policy (DCCT, 1993, National Institute for Health and Care Excellence; NICE, 
2015).  
Adolescence is a notoriously challenging time of biological, psychological and social 
changes, and adolescents with IDDM must manage such changes in the context of a strict 
regimen of blood tests, diet, activity and insulin injections (Burke & Dowling, 2007). This 
developmental period is often characterised by poor glycaemic control, with four out of five 
adolescents unable to achieve their target for control (Spencer, Cooper & Milton, 2010). 
Generally, adolescents have poor glycaemic control and this poses a significant challenge to 
diabetes healthcare teams regarding how best to intervene to prevent potential life-changing 
or life-limiting complications (Burke & Dowling, 2007). Given the size of this health 
problem, and in order to improve service delivery and the quality of care provided, previous 
research has endeavoured to identify reasons why young people are non-adherent to treatment 
regimens (Scholes et al., 2013). The existing literature explores ‘barriers’ to control and 
focuses upon the negative impact of IDDM; it is ‘problem saturated’, focusing upon distress 
and the subsequent negative psycho-social consequences of IDDM (Balfe et al., 2013). The 
extant quantitative research is dominated by correlational studies that aim to measure various 
psychological constructs associated with distress (Balfe et al., 2013). In the past decade there 
has been a renewed focus on qualitative investigations, although they have continued to 
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explore perceptions and experience of IDDM in the context of distress and negative impact 
(Balfe el al., 2013; Samson, 2006; Scholes et al., 2013).  
The NHS defines ‘healthy living with diabetes’ as the successful management of the 
condition, for example: managing blood glucose levels and taking action to lower other 
physiological risk factors such as losing weight, stopping smoking, eating a balanced diet and 
being active (NHS, 2015). This medical definition places emphasis on the control of 
symptoms and fails to take into account the psychological, emotional and social aspects of 
wellbeing. Such an approach is evident in healthcare policy that places great emphasis on 
HbA1c results and assumes that a near normal HbA1c value is indicative of one living their 
life well (NICE, 2015). Northam, Matthews and Anderson (2004) propose that the 
psychological wellbeing of young people with IDDM should not be compromised at the 
expense of striving for near normal bio-medical indicators such as HbA1c. The relationship 
between HbA1c and quality of life in adults is unclear (Camacho, Anderson & Bell, 2002). It 
cannot be assumed that young people who are managing their blood glucose levels are, 
therefore, ‘living well’. Harris and Wallace (2012) on behalf of The Institute of Medicine 
consider the mental health and social aspects of ‘living well’ as:  
‘the best achievable state of health that encompasses all dimensions of physical, 
mental, and social well-being. Living well is shaped by the physical, social, and cultural 
surroundings and by the effects of chronic illness—not only on the affected individual, but 
also on family members, friends, and caregivers’. (p. 3) 
Spencer et al. (2010) identified that developing independence and autonomy in 
adolescence with IDDM was a complex process, and parents and peers could help facilitate 
such a process as well as hinder it. The successful management of IDDM occurred in the 
context of positive relationships with significant others in social environments (Spencer, 
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Cooper & Milton 2013).  Samson (2006) identified the importance for adolescents of 
accepting the condition and integrating it into their life, and this was aided by having 
knowledge, coping skills and support.  
Socially, adolescents were concerned about the impact of IDDM upon the sense of 
self, stigma, feeling different and being judged (Spencer et al., 2013). Balfe et al. (2013) 
proposed that IDDM could impact upon identity and identified the influence of the public 
view of IDDM and negative media representations.  
Balfe et al. (2013) proposed that adolescents had strong fears of diabetes related 
complications and death. Kyngas and Barlow (1995) and Samson (2006) identified how 
IDDM posed a threat to their physical, psychological and social wellbeing, and that they 
experience worry and fear in regard to pain, death, fear of going blind and the impact upon 
their mood. Paradoxically, some adolescents viewed IDDM as a unique opportunity to live a 
healthy lifestyle. 
The existing research reported conflicting findings that are littered with 
inconsistencies in theoretical and conceptual approaches, methodology, design, setting, 
reflexivity and further compounded by narrow definitions of health, quality of life and 
wellbeing (Spencer et al., 2010). There is a need for positively framed qualitative research 
exploring the lived experience of young people in the UK (Spencer, et al., 2010).  The focus 
of this research is to explore qualitatively how some young people are able to experience 
themselves as living well in adolescence despite IDDM.  It is hoped that this positive 
psychological approach will address a gap in the literature. It may help deepen the 
understanding of the psychological and social processes that enable some young people to 
live well with their condition and this, in turn, may help inform clinical practice. 
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Study aims  
To explore what ‘living well’ with IDDM means to a group of adolescents, and to 
offer an interpretative account of their experience at such a challenging time of development. 
 
Method 
Design 
The present study explored qualitatively how adolescents aged 13 to 19, who 
experience themselves as living well with IDDM, successfully negotiate the developmental 
challenges of adolescence and experience themselves as able to ‘live well’ despite their 
chronic condition. 
Sample and recruitment 
A purposive sample of eight participants was recruited from a paediatric community 
diabetes service in the north of England. Smith, Flowers and Larkin (2009) propose that 
participant sample size is determined by “data richness”, although a sample between four and 
ten participants is sufficient for doctoral research. Whilst the definition of “rich data” is a 
subjective one, the decision was made after seven interviews that an eighth would offer 
sufficiently rich and reflective accounts of the participants’ lived experience.  
The inclusion criteria comprised: aged from 13 to 19, diagnosed with IDDM, self-
identifying as ‘living well’ with IDDM. The exclusion criteria consisted of: unable to 
converse in English, adolescents looked after by the local authority, complex social care 
histories, significant and known mental health difficulties, behavioural difficulties or other 
complex medical needs. 
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Participants 
Table 1 
Participant characteristics 
Name Sex Age at 
interview 
Age at 
Diagnosis 
(years) 
Duration 
of IDDM 
(years) 
Treatment  
Amber Female 18 9 9 Injection  
Fiona Female 16 9 7 Pump  
Charlotte Female 14 11 3 Pump  
Harriet Female 17 7 10 Pump  
Ellis Male 18 15 3 Injection  
Barry Male 18 13 5 Injection  
Gary Male 14 4 10 Pump  
Dean Male 17 1  16 Injection  
 
Table 1 describes the sex, age, age of diagnosis (years), duration of IDDM (years) and 
treatment method. 
Data collection 
Data were collected using semi-structured interviews undertaken by the main 
researcher. This allowed the freedom and flexibility to respond to, and explore, what the 
participants felt important, and this facilitated a thoughtful and reflective account of their 
experience.  
Interview guide 
The interview guide (Appendix 2) was developed in keeping with the aims of the 
study. Initially, it explored the participant and their family, interests and hobbies, as well as 
school or college and strengths. The guide progressed to questions concerning participants’ 
understanding of IDDM and the diagnosis. The focus of the interview was their experience of 
living well physically, emotionally, psychologically, socially and behaviourally, as well as exploring 
family, school and peers. The interview concluded with coping and resources, and participants’ 
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strengths and qualities, as well as allowing them time to add anything they felt the interview 
failed to explore or capture.   
NHS ethical and research governance approval 
Sponsorship was provided by the University of Liverpool (UoL001214; Appendix 3) 
and NHS ethical and research governance approval (IRAS ID 200898; Appendix 4) was 
attained in accordance with requirements. 
Procedure  
Recruitment posters and flyers were left in the clinic waiting area in the paediatric 
diabetes outpatient clinic. Clinic staff were briefed prior to commencing recruitment, and it 
was clinic staff facilitating review appointments who offered an information flyer to those 
whom met the inclusion criteria. The lead researcher was often present in the department to 
offer further information. Interviews were arranged via telephone or email approximately two 
weeks after the potential participants first expressed an interest. One interview took place at 
the hospital site, the remaining were undertaken at participants’ homes. Those aged 16 or 
over provided written consent, whilst those who were younger provided assent and parental 
consent, after being given time to consider the recruitment flyer (Appendix 5), participant 
information sheet (Appendix 6), consent and assent forms (Appendix 7 and 8), parent 
information sheet (Appendix 9), and ask any questions. The interview guide was used 
flexibly to promote self-reflection and discovery. Interviews varied in length from 35 to 63 
minutes. Following the interview, a debrief sheet was given that detailed hospital contact 
details, complaints and helplines (Appendix 10). Interviews were recorded with a digital 
Dictaphone and transcribed verbatim. Each participant was given a pseudonym to preserve 
their confidentiality and anonymity; therefore, the quotes used have been carefully selected in 
keeping with this. Interviews were conducted between January and May 2017. 
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Methodology 
Interpretive Phenomenological Analysis (IPA; Smith et al., 2009) aims to understand 
how people make sense of their personal and social world; it draws upon phenomenology, 
hermeneutics and idiography (Smith, 2011). Acknowledging that there is no direct route to 
capture experience, IPA aims to get as “experience close” as possible to the phenomenon. 
IPA allowed an exploration of an “experience close” phenomenon (living well) from which 
the researcher interprets meaning. Therefore, the researcher is making sense of the individual 
who is making sense of themselves as an adolescent who lives well with IDDM. The 
researcher meaning-making is what constitutes the ‘interpretative’ aspect of IPA. IPA shifts 
between staying close to the individual’s account and meaning-making, to analysis of aspects 
of the individual’s experience that they may not be aware of or choose to share (Smith & 
Osborn, 2008). IPA provides a means to capture the complexity of human nature, experience 
and relationships. 
The theoretical underpinnings of IPA position it well to offer an interpretation of how 
adolescents live well with IDDM. The lead researcher engaged in a reflexive process 
throughout via a reflexive journal (Appendix 11) and regular supervision.  
Reflexive statement 
The lead researcher is a 34-year-old white British male who had very little knowledge 
of IDDM and clinical health psychology prior to the research, although he had clinical 
experience of working with adolescents for a number of years, and had a longstanding 
interest in adolescent development and developmental psychology theories. The lead 
researcher was curious about how young people experience themselves as able to live well 
with a chronic condition, paying particular attention to issues such as quality of life, coping, 
resilience and applying psychological theory. Attempts were made to ‘bracket’ the lead 
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researcher’s previous experience of working with adolescents, particularly regarding 
interviewing and analysis, although his own life experience, beliefs, values, assumptions and 
experience of adolescence, illness and the health service would have inevitably and 
reflexively influenced the interpretation. Access to regular supervision, a reflexive journal 
and a transparent analysis with a clear audit trail mitigated such influence. It was anticipated 
that adolescents would prioritise their life and not be too concerned regarding blood glucose 
control or HbA1c results; however, what was found, on the whole, was the opposite.  
Analysis 
The IPA process of analysis was undertaken according to Smith et al.’s (1999) 
guidelines. Transcripts were analysed individually. First each transcript was read multiple 
times with initial noting of descriptive comments, linguistic comments and themes (Appendix 
12). From this, emergent themes were identified and clustered to form superordinate themes 
for each transcript (Appendix 13). The superordinate themes were clustered across all eight 
transcripts to provide a set of master themes and associated sub themes.  
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Table 2 
Transcript extract to illustrate the analytic process 
Quote (Amber) Exploratory coding Emergent themes Superordinate 
themes 
Subtheme Main theme 
Yeah, well, just in case, say 
if my sugars were to go low, 
and I didn’t have any sugar 
with me, that could lead to 
me passing out or even worse 
it, err, (intake of breath), I 
could go into a diabetic 
induced coma 
“just in case” – always 
having to be prepared / on 
guard. Fear regarding lack 
of control – fear of 
consequences of low 
blood sugar. Intake of 
breath – death. Risk of life 
limiting consequences and 
death  
Always prepared 
 
Perpetual anxiety 
regarding control 
 
Dodging death 
 
Fighting the risk 
of life changing 
complications or 
death 
 
‘no escape’ – 
perpetual anxiety 
regarding blood 
glucose control  
 
Fear of death and 
life-limiting 
consequences and 
death  
Using control to 
reduce the fear 
associated with life-
limiting 
complications and 
death 
 
The day to day 
management of the 
dynamic nature of 
IDDM 
 
Table 2 illustrates an example of the analytic process. 
 
 
Quality and validity  
All Transcripts, notes, reflections, individual analyses and final analysis were shared 
and discussed in supervision with the primary supervisor, and shared via email with the 
second supervisor. In addition to quality supervision, a reflexive journal helped raise 
awareness of the lead researcher’s relationship with the research, interpretation and findings. 
“Yardley’s (2008) framework for quality in qualitative research was considered with 
particular attention to the four broad principles: sensitivity to context; commitment and 
rigour; transparency and coherence; and impact and importance. In practice, the lead 
researcher paid attention to sensitivity to context during the interviews and analyses. During 
the interviews and analyses the lead researcher reflected upon the sociocultural and linguistic 
context of participants as well as reflexivity and power, and how these may have influenced 
what participants said and how it was interpreted. The lead researcher considered 
commitment and rigour by adhering to the process of the research and undertaking a 
systematic and thorough overall analysis that remained true to the principles of IPA; the 
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details of this process are described throughout the methods section. Furthermore, the 
analytic process was undertaken in the context of supervision and was open and transparent, 
which means that it had a clear audit trail. Finally, impact and importance were considered. 
Great care was taken to produce findings that would be of use clinically and inform practice, 
and these are offered in the paragraph on clinical implications.” 
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Results 
Table 3 
Master themes and Subthemes 
Master themes Subthemes 
1. Emotional security in and from close personal 
relationships 
1.1 Family relationships as a secure base to living 
well 
  
1.2 Using close personal relationships to manage 
distress 
  
1.3 The importance of friends and social activities 
 
 
2. The day to day management of the dynamic nature 
of IDDM 
2.1 Becoming unwell: Fear of the unknown 
 
 2.2 IDDM and the impact on identity in adolescence 
 
 
2.3 Accepting the diagnosis of IDDM 
 
  
 2.4 Using control to reduce the fear associated with 
life-limiting complications and death 
 
 2.5 Self- imposed limits in order to have a life 
without limits 
 
2.6  Living in an uneducated society 
  
  
3. “Living a normal life: Doing the same things that 
other kids do”  
3.1 A life of love, passion, happiness, purpose and 
meaning 
  
3.2 Living well as defined by a HbA1c target 
  
3.3 Looking to the future with hope and optimism 
 
 
4. Psychological resilience: The importance of a 
 positive mind-set 
 
 
 
 
 
 
 
4.1 Learning to live well 
 
4.2 Personal characteristics that promote living well 
 
4.3 Knowing your own mind 
 
4.4 Knowing where to turn for support 
 
 
Table 3 illustrates the four master themes and their constituent themes. 
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Master theme 1: Emotional security in and from close personal relationships   
The first master theme captures the fundamental influence of close personal 
relationships and how they promote emotional security.  
1.1 Family relationships as a secure base to living well 
Family relationships fostered a sense of security, safety and stability. Amber:   
“I have always had my family with me… I have always been very close to my sister and that 
is something that has never changed, and my mum too, and also my dad…we are a happy 
family.” 
In addition to stability and security, parents offered emotional and practical support; 
they often co-regulated blood glucose in the early stages, and in this respect parents modelled 
good care and adjustment. Barry illustrated this: “My mum, she tackled it head on… for the 
first year she tested a few times during the night to make sure my blood hadn’t gone down.” 
Barry later acknowledged that his mother’s behaviour may have been fuelled by her anxiety 
in regard to him having IDDM. 
1.2 Using close personal relationships to manage distress 
Distress was communicated and regulated in the context of close personal 
relationships, it was often the main carer who helped regulate difficult, negative emotions; 
although, this also applied to peer relationships. Harriet: “If I… feel down I can speak to my 
parents or speak to my friends. My friends… they’ll distract me or they’ll just remind me of 
good things and help me feel better… [parents] they approach it more head on… talk 
through it and work out any issues that I might have.” 
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The main carer and clinic staff were available in times of crisis. Charlotte: “I didn’t 
know what to do, I was like crying, in the end my mum had to come home from work to come 
and sort me out.” 
1.3 Importance of social activities and friends 
Socialising was important to each participant; furthermore, a supportive peer group 
appeared to help the participants feel socially accepted and experience a sense of acceptance 
in regard to IDDM. Amber: “Socialising is really important to me and friends… my friends 
were all accepting of it… I am fortunate enough to have friends who I was surrounded with 
that were just very accepting of it.”  
Master theme 2: The day to day management of the dynamic nature of IDDM 
Participants described several challenges as they managed IDDM on a day to day 
basis. Experiencing serious physical health problems, having contact with health 
professionals and being told they were ‘ill’ with a condition for which there is no ‘cure’, was 
experienced as frightening and confusing. All participants described IDDM as having an 
impact on their identity and the importance of accepting the condition. Furthermore, 
participants described controlling their blood glucose (often out of fear) and this involved 
self-imposed limits, as well as living in the context of an ‘uneducated’ society.   
2.1 Becoming unwell: fear of the unknown 
Participants described the experience of being ‘ill’, going to hospital and then being 
told they had IDDM as frightening. Amber: “It was really scary… I had never had anything 
wrong with me, so that was my first time being admitted to hospital with something that was 
serious – it was quite scary for me.” Furthermore, this had implications for adjustment and 
loss, for example, the loss of freedom and being able to eat freely.  
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2.2 IDDM and the impact on identity in adolescence 
IDDM posed a threat to the physical and psychological wellbeing of participants; they 
questioned why they had developed the condition, experienced powerful emotions such as 
anger, and longed to be ‘normal’. This impacted upon identity and the sense of self. Amber 
describes how she accepted and integrated IDDM as part of her identity:  
 “As I have got older, I look at diabetes as something that just defines me, it’s part of me, and 
when I was younger… I just thought I have to be like everyone else… [as I have] grown 
through all of my adolescent years… if I didn’t have diabetes I wouldn’t be me… it is a part 
of who I am.” 
2.3 Accepting the diagnosis of IDDM 
Accepting the condition appeared important in the process of gaining the knowledge 
to manage the dynamic nature of IDDM and integrating self-care into a daily routine. Barry 
helpfully summarises this, as well as some previous themes: “I think that accepting it and it 
being part of your lifestyle, not being in denial, helps quite a bit… at the end of the day it is a 
part of you.”  
2.4 Control as a strategy to reduce the fear associated with life limiting complications 
and death 
Failure to control blood glucose often meant feeling physical unwell, serious illness 
and potentially, risk of death. There was perpetual anxiety regarding control.  Amber: “It 
does impact everything I do, if I ever want to leave the house… I always have to have… all of 
my equipment just in case, there is always that element of just in case, you just have to carry 
it with you all of the time, there is never an escape from it is what I am trying to say, it is 
always there.” 
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The fear of complications motivated participants to stay in control. Ellis: “That’s one 
of the reasons why I mainly keep on top of it. When I think about going blind I just think no! 
Not going blind, so try and keep me bloods the best I can.”  
2.5 Self- imposed limits 
Amber described self- imposed limits: “I feel like with diabetes, I can drink, but I 
know my limits, I feel as though my diabetes never stops me from [drinking alcohol]… I 
always try not to drink too much or if I have a couple of drinks I will always know when to 
stop.” Most participants did not drink alcohol and enforced their own limitations and 
restrictions. Furthermore, this allowed them to feel in control of the IDDM, rather than them 
feeling controlled by the IDDM.   
Participants described benefits to IDDM; for example, being more health conscious. 
Barry: “knowing that it benefits you in the long term, cos, a lot people [without IDDM]… 
don’t eat healthily or exercise.” 
2.6 Living in an uneducated society 
Participants described a lack of understanding from the public, and that this may be 
fuelled by negative media images, and at times may influence how the participants 
themselves make sense of their condition. Charlotte: “When I first went to hospital, I didn’t 
even know it was a thing, I had heard briefly about it – but I thought it was just this thing that 
fat people got.” Participants described how IDDM is an invisible condition and that you do 
not know what it is like to live with IDDM unless you have it; therefore, participants 
described feeling uncomfortable at misinformed or inappropriate comments or jokes, for 
example, a person referring to a bowl of sweets as “a bowl of diabetes” (Amber). 
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Master theme 3: “Living a normal life: doing the same thing that other kids do” 
Participants’ lives were often full of enjoyable and varied interests and activities, and 
similar to the lives of adolescents who do not have IDDM. It was important that adolescents 
with IDDM enjoyed “living a normal life, doing the same things that other kids do” (Dean).  
3.1 A life of love, passion, happiness, purpose and meaning 
Participants described living a life of love, passion, happiness, purpose and meaning; 
therefore, the nature of living well was subjective. Dean: “People have their own way of 
living well… Everyone has to have something they like to do and everyone has to have 
something they have to love.”  
This theme was social in nature and closely related to the previous theme highlighting 
the importance of friendships and social activities; therefore, living well was influenced by 
popular culture and society. 
3.2 Living well as defined by a HbA1c target 
Steady blood glucose was important in living well and could be quantified by HbA1c 
results and targets. Therefore, living well was defined by blood glucose level and an HbA1c 
target. Most participants were goal orientated and valued this, others experienced guilt and 
shame when they failed to meet the set target. Amber was target driven: “With my average 
when I come to clinic, if they are a point higher than they were, I would be driven to get them 
back down, doing more exercise, being more conscious of my insulin.” Gary found meeting 
the target difficult: “I’d like slip up and forget or something and then I’d get in trouble with 
the doctors and that.”  
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3.3 Hope and excitement about the future 
Participants were hopeful, optimistic and excited about the future. Achieving goals 
and succeeding appeared to promote a sense of mastery and success, which in turn promoted 
confidence and self-esteem. Charlotte: “I’m in set one for a lot of subjects, so I do quite well 
at school… I wanna go to university and college and do all that…I wanted to be a doctor.”  
Master theme 4: Psychological resilience: The importance of a positive mind-set 
Participants described a range of cognitive strategies that they used to help themselves 
live well, generally, this comprised of always trying to remain positive: “a positive mind-set”, 
and this included focusing upon the positives rather than the negatives.  
4.1 Learning to live well 
Participants had learned from experience, they described the ability to be self-aware, 
reflect, value feedback, face difficulties and overcome them. Amber: “I have just taught 
myself to, erm, live with it… I think that just going through the experience, just growing with 
it.” 
4.2 Personal characteristics that promote living well 
Participants described a range of personal characteristics that promoted living well; 
they were mature, involved in education, often creative and took personal responsibility for 
independently managing blood glucose. Amber: “it made me grow up in a sense that I wanted 
to be independent doing my own medication, so I think that’s probably just the type of person 
that I am anyway.” 
Participants experienced themselves as perfectionistic, well-motivated and 
determined. Amber continues: “After kinda accepting that I had it, I was just determined to 
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take it on, learn more about it and treat it myself… I’d say that I am a bit of a perfectionist… 
most days I am a go getter, yeah, I can do this.” 
Participants developed confidence practicing self-care in front of others and talking to 
other people about IDDM; furthermore, they appeared socially skilled and felt comfortable 
asking for help. 
4.3 Knowing your own mind (cognitive strategies) 
Participants described using a range of cognitive strategies they would employ to 
cope; they were aware of their own thoughts and thinking style, and what thoughts to engage 
with and how this left them feeling and behaving.  They were aware of the downward spiral 
of negative thoughts and negative behaviours, and in this respect they felt it best to avoid 
engaging in rumination. Barry: “I think a negative outlook can lead to negative behaviour, 
kinda self- deprecating behaviour in a way, because, if you think in a negative way you are 
going to generally have negative habits.”  
Distraction and the use of positive self-talk were frequently mentioned as strategies to 
manage negative emotions.   
4.4 Knowing where to turn for support 
Each participant had a subjective view in regard to what they found supportive. The 
participants felt supported at the clinic; it was clinic staff who directed them towards 
particular resources such as literature, online groups, new technology and diabetic events or 
holidays. Ellis: “you can go to them for support, [online groups] you can ask them stuff and 
that’s great like, I don’t really use it much because I get by fine, but it’s nice knowing they’re 
there for you.” 
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Discussion 
This study identified that the experience of ‘living well’ for adolescents with IDDM 
encompassed having a ‘normal’ life in which one lived how one wanted to, similar to 
someone without IDDM, experiencing pleasure and enjoyment in pursuit of interests. 
Paradoxically, some participants restricted themselves in order to feel unrestricted by IDDM, 
and in this respect self-imposed limits provided the freedom for them to do whatever they 
wanted to. Living well was characterised by a happy and enjoyable life, which has purpose, 
meaning, love and where one can pursue passions, interests and activities, particularly social 
activities with friends. Participants found goals and targets helpful, they wanted to achieve 
and succeed, and looked to their future with hope and optimism. ‘Living well’ was subjective 
and comprised many aspects of the person’s life, and was influenced by popular culture and 
society. This is in keeping with The Institute of Medicine (Harris & Wallace, 2012) definition 
of living well.   
Participants described how steady blood glucose and an acceptable HbA1c was 
commensurate with living well. Whilst some participants valued HbA1c targets, others 
described how failing to meet such a target left them with feelings of guilt and shame. 
Furthermore, meeting the HbA1c target does not necessarily equate to living well, as good 
control may be fuelled by fear of IDDM complications or death. 
Living well meant feeling emotionally secure and stable, and managing negative 
emotions; this occurred in the context of close personal relationships with family, peers and 
clinic staff. This is in keeping with earlier studies by Spencer et al. (2013), Burke and 
Dowling (2007), Samson (2006), Balfe et al. (2013) and Scholes et al. (2013); therefore, this 
study supports previous evidence that supportive family and peer relationships are 
experienced as promoting living well with IDDM. This emphasises the relational context of 
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life as an adolescent with IDDM, and the developmental psychology theory of attachment 
may help to improve the understanding of the fundamental role of significant others and 
relationships in living well. According to Bowlby (1958), an attachment is a bond or tie based 
on the need for safety, security and protection. Infants are born with basic instincts, they are 
immature and vulnerable, and entirely dependent upon their caregivers for protection and 
survival. Infants seek proximity to their caregiver at times of threat, and secure attachment is 
characterised by sensitive and responsive caregivers that are emotionally available, offer 
reassurance, warmth, protection and the provision of comfort (Ainsworth, Blehar, Waters & 
Wall, 1978; Cassidy & Shaver, 2008).  
Ainsworth et al. (1978) proposed that caregivers offer a secure base which allows the 
child to develop and explore, and attachment has been associated with emotional regulation, 
reflective functioning, positive self-concept and prosocial behaviour; therefore, it could be 
argued that healthy relationships at home promoted the development of positive social 
relationships with peers and this may explain the findings in this study (Cassidy & Shaver, 
2008). This may indicate the importance of secure attachment in facilitating living well in 
adolescence with IDDM, particularly the activation of attachment behaviour in times of 
threat, for example being diagnosed with IDDM, and the need for an appropriate response 
from significant others. 
Family and peers offered both practical and emotional support; this is in keeping with 
the seminal text of Lazarus and Folkman (1984) and their model of stress appraisal and 
coping.  Parents and peers provided practical assistance and reminders to help regulate blood 
glucose, as well offering emotional support.  
The challenging journey from denial and avoidance to accepting the condition 
illustrated the powerful, negative emotions associated with the diagnosis of IDDM. Denial 
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and avoidance appeared protective in the short term, and these are common psychological 
defence mechanisms (Leiper, 2014). Kübler-Ross (1969) proposed a series of emotions are 
experienced by those facing the onset of disease and typically include denial, anger, 
bargaining, depression and acceptance. Participants in this study described denial and 
avoidance when diagnosed, and this progressed to anger and ‘why me?’ Participants appeared 
to accept the condition but continued to experience negative emotions. This may help 
understand the challenges faced by an adolescent who has been diagnosed with IDDM 
(Kübler-Ross, 1969).  
Socialising and social friendships were of prime importance, and this can be 
understood in the context of adolescent development. This is also in keeping with previous 
research by Spencer et al. (2013), where participants wanted to be seen as normal and social 
relationships influenced their identity. This is supported by Erickson (1963) and his theory of 
psycho-social development. Stage five occurs in adolescence: identity versus role confusion. 
Positive social relationships allow the person to develop a sense of self, personal identity, 
independence and control. This relates directly to Amber’s transcript and the importance of 
peers, socialising, being accepted and acceptance, as well as wanting to be independent, 
wanting to control her IDDM and integrating IDDM as part of her identity.  
Participants described experiencing low mood and anxiety in regard to adolescent 
development, wanting to be normal, and adjusted. Therefore, despite participants self-
identifying as living well, they still experienced powerful negative emotions, particularly 
fear. This was largely a fear of life-changing complications such as going blind, and this was 
used as motivation for good control. This suggests that even those adolescents who appear to 
live well, present with good glucose control and meet the required HbA1c targets, do so 
because they fear the consequences of not being in control. Therefore, they experience and 
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manage high levels of anxiety on a daily basis and control their diabetes out of fear. This is in 
keeping with earlier research by Kyngas and Barlow (1995) and Samson (2006). 
Participants described paradoxical statements, such as self-imposed limits in order to 
have a life without limits. Therefore, some participants restricted themselves in order to feel 
unrestricted by IDDM, and this may have allowed them to feel in control of the IDDM rather 
than them feeling controlled by the IDDM. Some participants believed that IDDM offered an 
opportunity to live well, and this is in keeping with prior research by Kyngas and Barlow 
(1995). 
Participants endeavoured to have a positive mind-set and in this respect the 
adolescents involved in this study were psychologically resilient. They strived to be the 
healthiest they could be and learned from set-backs and difficult times. Each participant had a 
range of personal characteristics that seemed to promote living well, for example: being 
involved in education, mature, independent, responsible, perfectionistic, well-motivated, 
determined, socially skilled, confident and able to ask for help.  
Participants described an awareness of the interaction of thoughts, feeling and 
behaviours. They recognised that rumination was unhelpful and used distraction and positive 
self-talk to cope with the powerful, negative emotions. Each participant had to recognise that 
they needed further support and know where and how to access support. Participants had a 
support network that included family, peers, clinical staff, using technology, literature, online 
support, and diabetic events and holidays. The participants described the importance of 
helping themselves and talking to their support network. 
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Conclusions  
This IPA study offered an interpretive account of how adolescents experience 
themselves as able to live well with IDDM. Participants wanted a ‘normal’ life and each 
individual had their own subjective view of living well. Generally, living well was a life like 
any other, with love, passion, interests, enjoyment and happiness. Living well meant steady 
blood glucose management and this often meant achieving a near normal HbA1c. HbA1c 
targets were beneficial for most but meant guilt and shame for some; therefore, there is more 
to living well than an HbA1c result. This study proposed that good blood glucose control 
could be fuelled by anxiety and the fear of life-changing complications such as going blind. 
Those who may appear to be living well may still experience powerful, negative emotions. 
Such emotions were often regulated in close personal relationships, and such relationships 
with family, peers and clinic staff fostered a sense of emotional safety and security, in 
keeping with attachment theory (Bowlby, 1958) and previous studies by Spencer et al. 
(2013), Burke and Dowling (2007), Samson (2006), Balfe et al. (2013) and Scholes et al. 
(2013). 
Family and peers provided practical and emotional support (Lazarus & Folkman, 
1984) and participants described powerful emotions throughout their adjustment, for example 
denial, anger, bargaining, depression and acceptance (Kübler-Ross, 1969). The participants 
described the importance of living a ‘normal life’, a fear of being seen as ‘not normal’, 
wanting to be accepted, independent and have a robust sense of self and identity (Erickson, 
1963). Participants expressed a series of seemingly paradoxical statements and had a range of 
personal characteristics that promoted living well. They were psychologically resilient and 
had a range of support available.  
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Strengths and limitations 
This is the first study to explore how adolescents experience themselves as able to live 
well with IDDM; therefore, this study adds to the limited research in this area.  
This qualitative research offers an interpretative account of how adolescents 
experience themselves as able to live well with IDDM, therefore, it is a subjective account of 
the experience of a small, homogenous group of adolescents and does not aim to be 
generalizable, and this may be seen as a limitation. A further limitation was the lack of 
service user involvement in the design of the study. The lead author approached local NHS 
service user involvement groups with the intention of involving young people in the design 
and layout of the participant information sheet, consent documentation and interview 
schedule; unfortunately, access could not be facilitated. Informal feedback regarding the 
interview schedule was elicited from young people and their families using the department. 
Recruiting participants that self-identify as living well may have meant that a particular type 
of person decided to participate, and it potentially failed to capture the experiences of less 
‘confident’ adolescents who are able to live well. Furthermore, adolescents may have wished 
to present themselves in a positive light and this may have meant that they presented 
themselves a particular way in the interview. Interviewer effects may have meant that 
participants were influenced by the interviewer (lead researcher).  
Clinical implications 
Participants valued the significant people in their lives and their relationships with 
them; this included clinical staff. It was important that these people were easily accessible at 
times of crisis. Participants wanted to live a normal life; living well and what participants 
found helpful was subjective, although participants generally valued literature, access to 
support groups, diabetic events or holidays and technology. Given that living well, and the 
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nature of what was experienced as supportive, were subjective, it is a reminder that each 
adolescent must be treated as an individual. For example, an HbA1c target was generally 
useful for those who valued goals, but the negative impact of failing to meet such targets 
meant guilt and shame for some. Therefore, clinical staff must consider the potential negative 
impact of setting such goals for everyone. Furthermore, the findings indicate that good 
glucose control may be motivated by fear of IDDM related complications, and that even 
those who may be living well, may still experience high levels of distress and negative 
emotion that may not be overtly expressed. Clinical staff must remain vigilant to the potential 
distress experienced by all adolescents, even those who may achieve HbA1c targets or appear 
to be living well. Psychologically informed individualised care plans may help mitigate the 
risk of distress and help conceptualise living well psychologically, emotionally, socially and 
behaviourally, as well as biologically.  
More broadly, participants described IDDM as an ‘invisible condition’ that is often 
confused with type 2 diabetes and associated conditions, as well as a general lack of 
understanding from the public and those without IDDM. Such ignorance is likely to impact 
on the potential for young people to live well; therefore, there is an urgent need to educate the 
public and society to address such misconceptions. This might be achieved via a general 
public health education campaign that offers greater clarity regarding the types of diabetes; 
for example tackling the stigma and misconceptions associated with IDDM. This may build 
on the existing campaign that encourages parents to look for the “four T’s” that are indicative 
of IDDM: becoming tired, increased thirst, increased toilet visits and becoming thinner. 
Existing paediatric diabetes teams could continue to offer educational programmes for 
children and families, as well as visiting schools and colleges to offer workshops to support 
staff and students. Furthermore, supportive literature and groups could be devised and 
facilitated to offer psychologically informed education and information. 
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Future research  
Future research may wish to develop a developmentally appropriate and 
comprehensive measure to assess QoL in children and young people with IDDM. Future 
research could explore the relationships between attachment style, coping style and QoL in 
adolescents with IDDM. 
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Appendix 2 
Interview Guide 
IRAS Project ID: 200898 
Topic Guide  
Version 3: 20/06/2016 
Introduction 
My name is Adam. I am the main researcher and will be interviewing you today. I wanted to tell you 
a little bit about what to expect. 
The main aim of the interview is to get a really good understanding of what it is like to be you, and 
how you live well with diabetes. There are no right or wrong answers. I want to know about your 
experiences and how you felt. I have some questions to help us. Some of them may sound unusual 
because they ask about your experiences –the questions are not made to try to trick you– if you do 
not understand, let me know, and I will ask the question differently. They start by asking about you, 
then they ask about the diagnosis, diabetes, living well and coping. This is just a guide, it is important 
that you talk about what is important to you, your experiences and feelings. The interview will 
probably not last longer than an hour – but that depends upon how much you talk! If you need a 
break or a rest then please let me know. I want you to be comfortable. Just like it says in the 
participant information sheet – if you wish to stop the interview at any point please let me know. 
1) Something about you 
1.1 Tell me about yourself and your family (who lives with you in the family home?) 
Prompts:  What are you interested in?  
  What do you enjoy doing in your spare time? 
  What are you good at?  
What about school / college? 
  Are there others in your family with diabetes? 
2) Diagnosis and your diabetes  
2.1 Can you tell me, in your own words, what is your understanding of diabetes? 
2.2 What do you remember about being told you have diabetes? 
Prompts: How old were you at the time?  
What was that like?  
How did that feel?  
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Can you give me an example of that? 
2.3 How did you feel about the diagnosis at the time you were diagnosed?  
(or at the time when you remember being told that you have diabetes) 
2.4 How did your diabetes affect you, when you were first diagnosed?  
(Physically, emotionally, socially & psychologically) ask as separate questions 
(At home, school & with friends) ask as separate questions 
2.5 How did that change over time? 
2.6 Have you had any particular health problems related to your diabetes, since you were 
first diagnosed? 
3) Living well with diabetes 
3.1 Can you tell me what it is like for you, having diabetes? 
3.2 Please talk me through a typical day, from when you get up in the morning to when 
you go to bed at night. 
Prompts: What is that like?  
How does that feel?  
Can you give me an example of that? 
3.3 What does the idea of living well mean to you?  
Prompt: how would you describe someone who is ‘living well’? 
Think of someone you would describe as living well – how would you describe them?  
3.4 Tell me how you are able to manage your diabetes and live well (achieve your goals…). 
Prompts: What do you do in order to achieve that (living well) (i.e. achieve managing your 
diabetes and living well with it)? Give examples. 
3.5 How does it actually feel to be living well with your diabetes? (How does it feel 
physically emotionally, psychologically, socially, behaviourally ?) ask as separate questions 
Prompts: How did you learn to do that? Give examples 
What helped most in learning to live well? Give examples 
3.6 Who helped or helps you to learn how to live well with diabetes? How did/do they do 
that? 
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4) Coping / resources   
4.1 What qualities or strengths do you have that helped you live well? 
Prompts: What is it about you that means you have been able to live well?  
Give me some examples 
4.2 What would your parents/carers/ brothers or sisters/ teachers/ friends say your 
strengths / qualities are? 
4.3 What were the worst (most difficult or challenging) bits of your journey to living well? 
4.4 How did you manage to get through those worst bits of your journey to living well?  
Give examples 
4.5 What advice would you give to other young people to help them manage? {and/or 
what advice would you give to others that might struggle to live well?}  
 4.6 Tell me about your main sources of support?  
Prompts: Who are they?  
In what way are they supportive?  
What do they do to be supportive? 
 
Anything else 
Is there anything else that you would like to say? 
Is there something that I have not asked about and you thought that I might have asked some 
question about that? 
Have I missed anything that you feel is important? 
 
Neutral prompts: 
Can you tell me some more about that? 
Please could you say more? 
Please could you give me an actual example of that? 
Tell me about a time when… 
How did that feel? 
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Appendix 5 
Recruitment Flyer 
 
Living well with insulin dependent diabetes in adolescence 
Version 1 27/07/2015 
IRAS ID: 200898 
 
Are you between 13-19 years old?  
 
Do you have insulin dependent diabetes?  
 
Do you feel you are living well with diabetes? 
 
If the answer to all of the above questions is yes… You may be able 
to help! 
 
As part of a research project, I would like to speak with young people 
to learn more about how they live well with diabetes… 
 
If you can help, please speak with a member of the team to find out 
more… 
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Appendix 6 
Participant Information Sheet 
 
 
 
 
 
 
 
 
 
 
 
Participation information sheet.  Version: 2. Date: 31/07/2016 
IRAS Project ID: 200898 
 
 
‘Living well with insulin dependent diabetes in adolescence’ 
 
Part 1 
 
What is research?  
 
• Research is done to try to answer important questions.  
 
Why is this research being done? 
 
• There is lots of research that says having diabetes is difficult to get used to. 
 
• There is very little research looking at how young people ‘live well’ with 
diabetes. 
 
• If you feel that you ‘live well’ with diabetes, we think you might be able to help. 
 
• The important question we want to look at is: 
 
How do young people manage to ‘live well’ with diabetes? 
 
We hope to find out the answer to this question so that young people get the 
best help possible. 
 
Why have I been asked to take part? 
 
• You have been asked to take part because you are between 13 – 19 years old 
and have insulin dependent diabetes.  
 
Do I have to take part? 
 
82 
 
• No. It is entirely up to you.  
 
• Before you decide to take part, you need to understand more about the study. 
If you are interested, please read Part 2. 
 
 
 
 
Part 2 
It is important for you to understand why the research is being done and what it will 
involve. Please read the following information carefully and ask if there is anything 
that you do not understand, or would like more information about. Please take time 
to talk to your parents, family, friends and health professionals if you would like to, so 
that you make the choice that is right for you. 
 
It is important that you know you do not have to take part, you should only 
take part if you would like to. If you do not take part it will not affect your 
treatment at the hospital. 
 
What will happen to me if I take part? What will I be asked to do? 
If you decide to take part and are able to take part in this study, then you will be 
asked to meet with me so that I can ask you some questions about what ‘living well’ 
with diabetes means to you, and how you manage to live well with diabetes. We can 
meet at Ormskirk hospital, at the University of Liverpool or at your home. We will 
usually try to meet you during office hours (9am – 5pm, Monday to Friday); although, 
we can be flexible so that the timing of the interview does not interfere with your 
usual commitments.    
 
Whilst there will be some questions to guide the interview, the main aim is to hear 
from you what is important to you. There are no right or wrong answers. You 
can talk for as little or as much as you like. The interview is not likely to last 
longer than an hour. If you decide to start the interview but then want to 
stop – you can stop without having to give a reason. You can stop the 
recording at any time and ask that words are deleted or replaced.  
 
 
Is there anything else to be worried about if I take part? 
We cannot foresee any risks to your health by taking part. It is unlikely – but you may 
feel upset when talking about your life - if you do get upset, you will be offered 
information about how to get further support, and if you would like to continue the 
interview or stop. 
 
The information that you give will be confidential - this means that it will be private – 
unless you are at serious risk of harm. If we find out something that we think is 
important about your health that may be relevant to your care we will talk to your 
mum, dad or carer. If you are at serious risk of harm, then information will be shared 
with other professionals. 
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Will the study help me? 
No, but the information we get will help us understand how young people manage to 
live well and enjoy life, even though they have diabetes. This might help improve the 
treatment offered to young people with diabetes. 
 
 
What if I don’t want to do the research anymore? 
You can stop the interview at any time. You can withdraw from the study up until the 
information has started to be analysed.  
 
 
What if there is a problem or something goes wrong? 
Tell us if there is a problem and we will try and sort it out straight away.  You can 
either contact the project co-ordinator or chief investigator, their details are at the 
end. 
 
You can also contact the Patient Experience and Complaints Team, they are 
independent of the research team. You can contact them at Southport and Ormskirk 
Hospital NHS Trust, Town Lane, Southport, PR8 6PN. Email: soh-
tr.complaints@nhs.net. Telephone: 01704 704958. 
 
Will anyone else know I’m doing this? 
The interview will be audio recorded and turned into words to form a transcript (a 
written record of the interview). The transcript will be analysed to find out how you 
live well with diabetes. The transcript will be given a pretend name so that no one will 
know what you have said. All information that is collected about you during the 
research will be kept strictly confidential. Any information about you that leaves the 
hospital will have your name and address removed so that you cannot be recognised 
from it.  
 
 
What happens after? What will happen to the results of the research study? 
When the study has finished, we will present our findings to other healthcare 
professionals in medical magazines, websites and at conferences. The findings will be 
anonymous, which means that you will not be able to be identified from them. If you 
would like, we can send you a brief summary of the findings. The results will also be 
included as part of the main researcher’s educational qualification.   
 
Who is organising and funding the research? 
The research is part of the main researcher’s qualification and is paid for by the NHS. 
No one will get any extra money for doing this research. 
 
 
Who has checked the study? 
Before any research goes ahead, it has to be checked by a Research Ethics Committee.  
This is a group of people who make sure that the research is OK to do and that it does 
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not cause any harm to anyone taking part.  This study has been looked at by the 
University of Liverpool, the local NHS and it has also been checked by the Research 
Department at this hospital. 
 
How can I find out more about research? 
For more information contact Adam Welsh at awelsh@liverpool.ac.uk 
 
If you would like to complain you can contact the project supervisor, Dr. Gundi Kiemle, 
via email: gkiemle@liverpool.ac.uk. 
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Appendix 7 
Participant Consent Form 
 
 
 
 
Committee on Research Ethics 
 
 
PARTICIPANT CONSENT FORM 
 
Living well with insulin dependent diabetes in adolescence 
IRAS Project ID: 200898 
 
Researchers: Adam Welsh, Dr. Gundi Kiemle, Dr. Jen Unwin, Dr. May Ng and Dr. 
Becky Simm 
 
  
Please 
initial 
box 
  
1. I have read and understood the information sheet dated: 27/07/2015. I have been given 
time to think about the information. I have been able to ask any questions that I wanted 
to and I am happy with  the answers.   
 
 
 
 
2. I understand that I must be 16 years old to consent to take part. If I want to take part and 
I am over 16 then I can make the decision myself and will write my own name at the 
end of this form.  
 
 
 
3. I know that I can decide not to take part and it won’t affect the treatment that I get at the 
hospital. I don’t even have to a give a reason why I don’t want to take part. 
 
4. If I do decide to take part I don’t have to answer anything that I don’t want to. I can stop 
at any time and I do not need to give a reason why. 
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Participant Name               Date                  Signature 
  
 
                 
Name of Person taking consent                          Date                   Signature 
 
       
 Researcher                                                         Date                         Signature 
 
 
Principal Investigator:               Student Researcher: 
Dr. Gundi Kiemle                                                                  Adam Welsh 
Doctorate in Clinical Psychology Training Programme       awelsh@liverpool.ac.uk                                     
Whelan Building University of Liverpool  
Liverpool                                                                                                                                                                                                       
L69 3GB 
Tel: 0151 794 5877/ 5534                                                                      
g.kiemle@liverpool.ac.uk                                Version 3. 31/07/2016. 
5. I know the interview will be audio recorded and a trained professional will then listen to 
the tape and type everything that I have said.  The typed sheets will then be analysed to 
explore how young people ‘live well’ with diabetes. I know there are laws that mean the 
information that I give you must be protected. This means that my interviewer will give 
the information a pretend name so that no one will know that it is me. I could try to help 
by not mentioning my details, other than my first name, in the interview. 
 
 
 
6. I know that I must not take part if I do not feel well or if I am in local authority care or if 
I have significant mental health problems. I must be able to speak English.                                                                                                                                       
 
7. In the interview, if I say that I am unhappy with my treatment, I will be told to contact 
the hospital patient advice and liaison team. If I say that I am being hurt by someone or I 
have hurt others, or I am taking part in serious crime, I understand that this information 
will be shared with other professionals. If I say that I am behaving in a way that may 
cause serious harm to myself, like not managing my condition, this information may 
also be shared with my healthcare team. Such decisions will be made in my best 
interest. 
 
8. I am aware that I can contact the student researcher, Adam Welsh, to request a summary 
of the results. 
 
9. I agree to take part in the above study.    
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Appendix 8 
Assent Form  
 
Committee on Research Ethics 
 
 
ASSENT FORM 
 
Living well with insulin dependent diabetes in adolescence 
IRAS Project ID: 200898 
 
Researchers: Adam Welsh, Dr. Gundi Kiemle, Dr. Jen Unwin, Dr. May Ng and Dr. 
Becky Simm 
 
  
Please 
initial 
box 
  
1. I have read and understood the participant information sheet dated: 27/07/2016. I have 
been given time to think about the information. I have been able to ask any questions 
that I wanted to and I am happy with  the answers.   
 
 
 
 
2. I understand that because I am under 16 years old then my parent / carer will give 
signed consent for me to take part.  
I must not take part if I am under 16 and no one is legally able to sign for me to take 
part. 
 
 
 
3. Even though an adult may write their name so that I can take part, I understand that it is 
up to me to choose if I want to take part or not. Just because my parent or carer thinks 
that it is a good idea for me to take part, it does not mean that I have to. If I do wish to 
take part then I can sign this assent form to show that I wish to take part.  
 
 
 
 
4. I know that I can decide not to take part and it won’t affect the treatment that I get at the 
hospital. I don’t even have to a give a reason why I don’t want to take part. 
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Participant Name               Date                  Signature 
  
                 
Name of Person taking consent                          Date                   Signature 
 
       
Researcher                                                          Date                         Signature 
 
Principal Investigator:               Student Researcher: 
Dr. Gundi Kiemle                                                                  Adam Welsh 
Doctorate in Clinical Psychology Training Programme                                                   
Whelan Building University of Liverpool  
Liverpool                                                                                                                                                                                                       
L69 3GB 
Tel: 0151 794 5877/ 5534                                                                      
g.kiemle@liverpool.ac.uk             awelsh@liv.ac.uk            Version 3. 31/07/2016. 
5. If I do decide to take part I don’t have to answer anything that I don’t want to. I can stop 
at any time and I do not need to give a reason why. 
 
6. I know the interview will be audio recorded and a trained professional will then listen to 
the tape and type everything that I have said.  The typed sheets will then be analysed to 
explore how young people ‘live well’ with diabetes. I know there are laws that mean the 
information that I give you must be protected. This means that my interviewer will give 
the information a pretend name so that no one will know that it is me. I could try to help 
by not mentioning my details, other than my first name, in the interview. 
 
7. I know that I must not take part if I do not feel well or if I am in local authority care or if 
I have significant mental health problems. I must be able to speak English.  
                                                                                                                                       
8. The interviewer will ask about how I live well with diabetes. If I happen to get upset, I 
understand that you care about my welfare and together we will make a decision about 
whether or not to stop the interview. It might be that you decide that it is in my best 
interest to stop the interview and I will respect that. 
 
9. In the interview, if I say that I am unhappy with my treatment my parents will be told to 
contact the hospital patient advice and liaison team. If I say that I am being hurt by 
someone or I have hurt others, or I am taking part in serious crime, I understand that this 
information will be shared with other professionals. If I say that I am behaving in a way 
that may cause serious harm to myself, like not managing my condition, this 
information may also be shared with my healthcare team. Such decisions will be made 
in my best interest. 
 
10. I am aware that I can contact the student researcher, Adam Welsh, to request a summary 
of the results. 
 
11. I agree to take part in the above study.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
Appendix 9 
Parent Information Sheet 13-15 Year Olds 
 
 
 
Parent / carer information sheet: 13 – 15 year olds 
  Version: 2. Date: 31/07/2016 IRAS Project ID: 200898 
 
 
‘Living well with insulin dependent diabetes in adolescence’ 
 
We would like to invite your son/daughter to take part in our research study.   
 
This study is interested in the experiences of young people aged 13-19 who have 
insulin dependent diabetes. Your son/daughter has been asked to take part because 
they are aged 13-15 years old, have insulin dependent diabetes, and are legally unable 
to provide informed consent for themselves. 
 
Before you decide if they can take part, we would like you to understand why the 
research is being done and what it will involve. Ask us if there is anything that is not 
clear or if you would like more information.   
 
 
What is the purpose of the research? 
There is lots of research that says having diabetes is difficult for young people to get 
used to. There is very little research looking at how young people ‘live well’ with 
diabetes. 
 
If you feel that your son/daughter is able to ‘live well’ with diabetes they may be 
able to help us. We want to find out more about how young people manage to ‘live 
well’ with diabetes. 
 
 
Why has my son/daughter been asked to take part? 
Your son/daughter has been asked to take part because they are aged 13-15 and have 
insulin dependent diabetes. Legally, they are unable to consent for themselves, 
therefore, you must be their parent or legal guardian and, if you would like them to 
take part, sign the consent form.   
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Do they have to take part? 
No. It is entirely up to you and your son/daughter. Before you decide that your 
son/daughter can take part you need to understand more about the study.  
 
It is important that you know your son/daughter does not have to take part, 
they should only take part if you would like them to. If they do not take part 
it will not affect their treatment at the hospital. 
 
 
 
What will happen to my son/daughter if they take part? What will they be 
asked? 
If you decide you wish for your son/daughter to take part (and they are able to take 
part in this study), then you will be asked to meet with me so that I can interview 
them. The interview could happen at the hospital (Ormskirk), at the University of 
Liverpool or at your home.  
 
So that your son/daughter can talk freely it is planned that they will be interviewed 
alone – with your permission.   
 
In the interview I will ask them questions about what ‘living well’ with diabetes means 
to them, and how they manage to live well with diabetes. Whilst there will be some 
questions to guide the interview, the main aim is to hear from them what they believe 
is important. There are no right or wrong answers. They can talk for as little or as 
much as they like. The interview is not likely to last longer than an hour. If they decide 
to start the interview but then want to stop – they can stop without having to give a 
reason. They can stop the recording at any time and ask that words are deleted or 
replaced. 
 
 
Is there anything else to be worried about if they take part? 
We cannot foresee any risks to your son’s/daughter’s health by taking part. It is 
unlikely – but they may feel upset when talking about their life - if they do get upset, 
they will be offered information about how to get further support, and if they would 
like to continue the interview or stop. At the end of the interview there will be a 
‘debrief’ and we will ask you to join us at that point. The ‘debrief’ will be a short 
conversation to discuss how your son/daughter found the interview and to make sure 
that they are OK. All participants will be given a debrief information sheet – this has 
useful telephone numbers for the hospital, and other telephone numbers and websites 
so that further support is available.  
 
The information that your son/daughter offers will be confidential - this means that it 
will be private – unless they are at serious risk of harm. If we find out something that 
we think is important about their health that may be relevant to their care we will 
discuss this with you in the ‘debrief’. If they are at serious risk of harm, then 
information will be shared with other professionals. 
 
Will the study help my son/daughter? 
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No, but the information we get will help us understand how young people manage to 
live well and enjoy life, even though they have diabetes. This might help improve the 
treatment offered to young people with diabetes. 
 
 
 
 
 
What if I don’t want my son/daughter to be part of the research anymore? 
Your son/daughter can stop the interview at any time. You can withdraw them from 
the study up until the information has started to be analysed.  
 
 
What if there is a problem or something goes wrong? 
Tell us if there is a problem and we will try and sort it out straight away.  You can 
either contact the project co-ordinator or chief investigator, their details are at the 
end. 
 
You can also contact the Patient Experience and Complaints Team, they are 
independent of the research team. You can contact them at Southport and Ormskirk 
Hospital NHS Trust, Town Lane, Southport, PR8 6PN. Email: soh-
tr.complaints@nhs.net. Telephone: 01704 704958. 
 
Will anyone else know my son/daughter is taking part? 
The interview will be audio recorded and transcribed (a written record of the 
interview). The transcript will be analysed to find out how young people live well with 
diabetes. The transcript will be given a pretend name so that no one will know what 
your son/daughter has said. All information that is collected about your son/daughter 
during the research will be kept strictly confidential. Any information about your 
son/daughter that leaves the hospital will have their name and address removed so 
that they cannot be recognised from it.  
 
What happens after? What will happen to the results of the research study? 
When the study has finished, we will present our findings to other healthcare 
professionals in medical magazines, websites and at conferences. The findings will be 
anonymous, which means that your son’s/daughter’s details will not be able to be 
identified from them. If you would like, we can send you a brief summary of the 
findings. The results will also be included as part of the main researcher’s educational 
qualification.   
 
Who is organising and funding the research? 
The research is part of the main researcher’s qualification and is paid for by the NHS. 
No one will get any extra money for doing this research. 
 
Who has checked the study? 
Before any research goes ahead, it has to be checked by a Research Ethics Committee.  
This is a group of people who make sure that the research is OK to do and that it does 
not cause any harm to anyone taking part.  This study has been sponsored by the 
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University of Liverpool, and approved by the local NHS and the Research Department 
at this hospital. 
 
 
How can I find out more about research? 
For more information contact Adam Welsh at awelsh@liverpool.ac.uk 
 
If you would like to complain you can contact the project supervisor, Dr. Gundi Kiemle, 
via email: gkiemle@liverpool.ac.uk. 
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Appendix 10 
Participant Debrief Sheet 
 
IRAS Project ID: 200898  
Living well with insulin dependent diabetes in adolescence. Version 1 27/07/2015 
Participant debrief sheet 
Thank you for taking part. We really appreciate you giving up your time to talk to us. 
We hope that you are feeling alright, now that we have come to the end of the 
interview. Please let me know if you are not feeling well right now. 
 
We would like you to know that if you have any questions about the research study, 
you can contact Adam Welsh at awelsh@liverpool.ac.uk 
 
If you would like to complain, you can contact the project supervisor, Dr. Gundi 
Kiemle, via email: gkiemle@liverpool.ac.uk.  
 
For further support, please see your named worker from the hospital: 
You can contact them on: 
 
You can also visit the following websites: 
The NHS: www.nhs.uk/Conditions/Diabetes 
Diabetes UK: https://www.diabetes.org.uk 
Diabetes UK also have a Careline so that people can telephone. The Careline is a 
support helpline for anyone with diabetes, their friends, family and carers. 
Telephone: 0345 123 2399 (Monday to Friday, 9am–7pm).Email: 
careline@diabetes.org.uk 
Other helplines are: 
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Young minds. Info line: 0300 123 3393. Text: 86463 (Monday to Friday, 9AM-6PM) 
Samaritans. Freephone: 116 123. (24 hours a day). Email: jo@samaritans.org. 
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Appendix 11 
Excerpts from reflexive journal 
Except One 
January 2017 
Following the first interview with Amber: 
It was a pleasure to meet with Amber. She seemed really keen to be interviewed and wanted 
to contribute to the research as much as possible. This left me wondering if the recruitment 
strategy (posters in waiting areas – seeking participants who self-identify as living well) may 
mean that a certain ‘type’ of person (i.e confident, sociable and outgoing) may be more likely 
to come forward to participate. Interestingly, Amber asked – “is it OK to mention the times 
when it isn’t good”. This made me realise that although she feels that she lives well, there are 
times when it is still very tough, and that she wishes to talk about these issues too. 
I was struck by Amber’s maturity, she seemed really organised and I remember thinking that 
she will definitely come to the appointment to be interviewed. She had a unique style and 
obviously took pride in her appearance. She was achieving all that she wanted to achieve, she 
valued her family, friends, good college, partner, work, driving and leisure opportunities such 
as hobbies and interests (music, guitar). She accepted the condition, was positive, looked 
forward to her future, she seemed perfectionistic and was compassionate. She seemed highly 
socially skilled and appeared to be very intelligent, thoughtful and articulate. Although she 
described how she was able to live well, it was not overly positive and it did not feel for my 
benefit or as though she was trying to impression manage – it felt very genuine. She was able 
to acknowledge the distress – there was an acceptance of the diabetes and the distress – and 
an acceptance that it was ok to have tough times – she would be compassionate to herself – 
she would sit and cry and believed that this was healthy. She was able to pick herself up and 
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to have a certain mind-set and use cognitive skills. My overall impression was that she was 
inspirational. I remember thinking that she should speak at a conference to enthuse staff and 
inspire other young people. I need to be aware of how positive and inspirational Amber’s 
story was to limit the impact on the analysis. 
 
Excerpt two 
Following supervision after the interview 
February 2017 
I was apprehensive about the interview guide and my interview technique, and for these 
reasons I wanted to discuss my interview technique in supervision. The interview and good 
interview technique is vital to generating data, and I did not wish to lead the participant. I 
wanted the participant to be able to be open and honest regarding their experiences. During 
the first interview, on occasions, I answered my own question, as well as offering some 
interpretation during the interview – this is something I need to be mindful of in future 
interviews. On the whole the interview was data rich, although, this may be because of what 
Amber brought to the interview. 
 
 Excerpt three 
Analysis 
March 2017  
 I have really enjoyed immersing myself in the data analysis; although, it has been a real 
challenge finding the right level of interpretation. I felt confident capturing the phenomenon 
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of living well but struggled to put ‘my stamp’ on it. With this, there is a risk of simply 
describing the data and thus risks not being IPA, as there will be a lack of ‘I’ – the 
interpretation. I have found this to be a real stumbling block. I feel that I have made some 
progress by stepping back from the data and the person (as I interviewed them and built a 
relationship with them) and this helped me - in some respects this is similar to offering an 
‘interpretation’ clinically – throughout assessment, formulation and intervention. It is difficult 
as I want to ‘get it right’, but this is influenced by positivist assumptions rather than the 
interpretivist approach that I am using. Yardley’s (2008) framework offers some clarity 
regarding what quality looks like in qualitative research.   
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Appendix 12 
Emergent Themes  Text              Descriptive Comments    Linguistic Comments     Conceptual Comments 
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Appendix 13 
Emergent Themes from Amber’s Transcript 
Amber F 18 
List of emergent themes - Themes grouped  
Family as a secure base   security and stability at home 
     Economic stability at home 
     Belonging to a happy family 
     Close family relationships 
     Mum as co-regulator of difficult emotions 
     Mum as co-regulator of blood glucose 
 
Living the life one wishes to live  A life well-lived with meaningful activities and interest that 
the person values 
 
Personal characteristics that appear 
 to promote living well Trying to be a positive person 
 The importance of having a positive mind-set 
 Taking personal responsibility for blood glucose control 
 A determination to independently manage the condition 
 Proactive response to diagnosis – accepting the condition, 
learning more about it and a personal zeal to manage it 
 Being goal orientated and target driven as a positive enabler 
for good blood glucose control 
 Self-awareness and an improved understanding of the self 
 Taking personal responsibility for living well 
 Self- belief to live the life one wishes to live 
 Doing everything one can to stay healthy 
 Valuing and respecting the self: Self-esteem, self-worth and 
self-care 
 Perfectionism as a positive enabler for good glucose control 
An extensive repertoire of coping  
strategies and skills  Accept what you can’t change 
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  Do your best to change what you are able to change 
  Choosing what thoughts to engage with 
  Focusing upon the positives one has in their life  
  Focusing upon one’s existing achievements 
  Focusing upon the positive rather than the negative 
  Feeling part of the diabetic community 
  Thinking that you are not the only one with diabetes 
  Thinking of people less fortunate as a coping strategy 
  Looking up to inspirational others demonstrates that  
  Believing that anything is possible 
  Putting on a front as a coping strategy 
  Expressing negative emotion as a coping strategy 
  Distraction as a coping strategy 
  Avoidance as a coping strategy 
  Gratitude as a protective factor 
The prime importance of social  
Relationships and social activity Friend’s promoting resilience via their acceptance of the  
  person and the diabetes 
  Relationships with other people with diabetes 
 
Learning to live well Learning to live well from experience  
 Learning to live well by doing 
 Knowledge and knowing what to do, and then doing it 
facilitates good health 
 The dynamic nature of IDDM 
 Taking the good days with the bad days 
Transition from health to illness 
 Mourning the life a person had prior to diagnosis 
 The emotional impact of IDDM 
 No knowledge of IDDM prior to diagnosis 
 The age of diagnosis and associated developmental 
challenges to understanding the condition 
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 Fear of negative appraisal from peers due to diabetes 
 Denial, avoidance and silence to cope in the early stages of 
diagnosis 
 Fear of standing out due to diabetes 
 Physical symptoms prior to diagnosis 
 Adjusting to the condition  
  
Diabetes never stops me Diabetes management becoming routine 
Related to later theme: Understanding diabetes as a condition not an illness 
Paradox of IDDM Wanting to lead a healthy lifestyle 
 Putting the diabetes in the context of what is important in 
life 
 Anything is possible as long as diabetes comes first 
 Diabetes comes first and you can achieve anything 
 Diabetes does not stop the person – because they stop 
themselves 
Confidence Confidence increase over time 
 Self-confidence as a positive enabler for good blood glucose 
control 
 ‘opening up’ about diabetes improves confidence 
 Talking to other about diabetes to educate them 
 Talking to others to increase empathy 
 Practicing self-care in front of others to boost confidence 
 
The perks of IDDM The physical benefits of being in good glucose control 
 IDDM as positive enabler as it make you more health 
conscious  
 Understanding restrictions as a positive enabler to improve 
health 
 Diabetes as a catalyst to personal maturity  
 Special treatment because of diabetes  
The challenges of keeping on top of  
the daily self-care tasks The challenge to stay motivated to practice good self-care 
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A life with restrictions, rules and 
 Routine A life with restrictions 
 Self-limiting to avoid limitations  
 Having to make sensible choices 
 Rules and routine as a positive enabler to stay healthy 
 Diabetes is something that needs caring for 
The paradox of managing the  
Condition (difficult but livable) Diabetes as a condition that limits achievements 
 IDDM means you sometimes miss out 
Diabetes as a dark cloud over the  
Person Longing to be normal 
 ‘I’m different’ 
 Searching for answers – why me 
 Fear of missing out 
 Negatives appraisal of one’s life in comparison to others 
who are normal 
 
Dodging death    realising that one is mortal 
     Diabetes as a threat to physical health 
     Fighting the risk of life changing complications or death 
Diabetes as a ball and chain /  
Imprisoned by diabetes   Loss of freedom 
The fear of life changing complications as a motivator for 
good diabetes management 
Perpetual anxiety regarding managing blood glucose 
Always having to be in control 
Staying in control to limit risks and stay safe 
Pre-occupied with control 
Being in control as strategy to manage anxiety and reduce 
risk of complications, and death 
One must be prepared at all times 
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Lack of understanding from the 
 general public     The general public as uneducated and ignorant regarding  
     diabetes 
     people that don’t have diabetes do not truly know what it is  
     like 
     you don’t  know about diabetes until you have it 
     The general public would be inept if one was to become 
 Unwell 
The general public are judgemental regarding IDDM  
The intolerance of others  
IDDM as an invisible condition 
Public situations as a barrier to self-care activities 
 
The challenges of managing IDDM  
in school    Exam pressure and stress and the impact on blood glucose
     Bullying       
Identity Accepting the condition as part of the self 
 Diabetes as accepted and integrated as part of the self  
  
The person feeling that only they can give themselves the care that they need 
Being depended upon insulin to feel well 
Stress influences blood glucose 
The importance of good engagement with healthcare services - Nurses offering practical advice and 
support 
